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Introduction
In the latest years, among scientific literature, many papers have been pub-
lished presenting mathematical models in cancer research field. They exam-
ine different biological aspects and use different mathematical tools.
In this work we focus on deterministic models concerning tumor-immune
system interaction, based on ordinary differential equations or delay differ-
ential equations. It has been done a critical reading of the existing literature
drawing our attention on a special family of models that we have then gen-
eralized. From this departing point we studied how adding of a delay term
can affect the system dynamics.
In biological phenomena, especially in tumor growth and development,
and in the tumor-immune system interaction, delays can be due to many
reasons (times of cellular division and displacement in the organism, time
lags from signals sending to their reception, times of synthesis and transport
of proteins, ... ), but often they are neglected in mathematical models that
are formulated using ordinary differential equations.
In this work, applying the theory of delay differential equations, we have
analyzed models behavior both with discrete and distributed delay, aiming
to stress the possibility of these systems to show an oscillatory dynamics.
As far as the examined literature is concerned, oscillations experimentally
observed in tumor growth are a feature hard to explain for scientists.
This research is mainly done looking for Hopf bifurcations. We use delay
as bifurcating parameter, in order to study if and how the delay can influence
the stability of the system and its dynamics. We proved that including a
delay term may cause - under some conditions - changes in the stability
of equilibrium points. Moreover, for some delay values, models can exhibit
limit-cycles that are not present in systems without delay.
The study has been run both analytically and numerically: we have
been dealing with different realistic examples whose parameter values, taken
from literature, were fitted from data sampled in clinical experiments. The
obtained results have been discussed both from a mathematical point of view
and for their medical-biological meaning. Finally, some simulations have
been conducted on a system to which has been added a term representing
delivery of a therapy (immunotherapy).
We took in exam both constant and periodic therapy, described with dif-
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ferent mathematical expressions, primarily focusing our numerical analysis
on the more relevant case of boli-based therapy.
As a result, varying therapy parameters, such as administration and
clearance time, we observed very interesting behaviors in model dynamics,
changes in stability properties and also resonance effects.
Contents are organized into six chapters.
The first reports basic results of theory of delay differential equations
and methods of analysis that are then utilized in following chapters.
In the second chapter topics of tumor-immune system interaction and
mathematical modeling are introduced and some relevant models are suma-
rized and discussed.
In third chapter a new model of tumor-immune system interaction is
presented and studied both analytically and numerically showing some bi-
logically meaningful examples.
Then the issue of immunotherapy is taken into account adding to the system
a treatment term and studying its behavior.
The fourth and fifth chapter are the core of this work. In these chapters
a delay term is added to model introduced in third chapter and obtained
delayed systems are studied analytically, with the aim to point out changes
in stability of equilibrium points, Hopf bifurcations and periodic dynamics.
Then delayed systems are studied numerically taking parameters within a
range of biological significance. In fourth chapter the delay term introduced
is a fixed lag delay, whereas in fifth chapter distributed delays are considered.
Finally the sixth chapter deals with immunotherapy in delayed models.
A numerical analysis was carried out for systems with delay and treatment
terms and many examples are showed and discussed, pointing out interesting
biological and mathematical features.
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Chapter 1
Basic theory of delay
differential equations
In many real processes, especially in the medical/biologic field, the dynam-
ics depends not only on the present state of the system, but also on the
past history of state variables. Modeling situations in which past history is
not negligible necessarily leads to the study of delay differential equations
(DDE).
In this chapter we report a survey of the theory ofDDE. In the first part
we give some basic definitions, existence, uniqueness and stability results.
Then we treat existence and stablity of periodic solutions stating the Hopf
Theorem for DDE.
Finally we describe some methods to study stability of delay system. In
the last chapter of this work we will deal with that again to analyze stability
properties and the occurrence of Hopf bifurcations in a family of models of
tumor-immune system interaction.
The following text [1] may be consulted on this topic; it exposes an
exhaustive theory of delay differential equations. In [2], [3] the matter is
handled paying special attention to the biological applications. Interesting
sections on equation with delay can also be found in [4] and [7].
1.1 Basic properties
Let r ≥ 0 be a real number and C = C([−r, 0],Rn) the Banach space of
continuous functions mapping [−r, 0], into Rn and the supremum norm. For
σ ∈ R, A ≥ 0, x ∈ C([σ− r, σ+A],Rn), and t ∈ [σ, σ+A], we define xt ∈ C
as xt(θ) = x(t+ θ), θ ∈ [−r, 0].
Let Ω be a subset of R × C, f : Ω → Rn a given function and denote the
right-hand derivative by a dot: ˙.
Then we call DDE(f) (delay differential equation) on Ω an equation of
7
1.1
CHAPTER 1. BASIC THEORY OF DELAY DIFFERENTIAL
EQUATIONS
the form:
x˙(t) = f(t, xt). (1.1)
A function x is said to be a solution of (1.1) on [σ−r, σ+A) if there is σ ∈ R,
x ∈ C([σ− r, σ+A),Rn), (t, xt) ∈ Ω and xt satisfies (1.1) for t ∈ [σ, σ+A).
Given σ ∈ R, ϕ ∈ C we say that x(σ, ϕ) is a solution of (1.1) with initial
value ϕ in σ, or a solution through (σ, ϕ), if there is A > 0 such that x(σ, ϕ)
is a solution of (1.1) on [σ, σ +A) and xσ(σ, ϕ) = ϕ. According to (1.1) the
right-hand derivative of the solution x at t is determined by t and by the
restriction of x(t) to the interval [t− r, t]. If the solution is unique, then for
every t ≥ 0 we can define:
T (t) : ϕ→ xt(σ, ϕ), (1.2)
that maps C into itself. T (t) is called the solution map of{
x˙(t) = f(t, xt), t ≥ σ,
xσ = ϕ.
(1.3)
We say that the equation (1.1) is linear if f(t, xt) = L(t, xt) + h(t), where
L(t, xt) is linear in xt; linear homogeneous if h(t) ≡ 0 and linar nonho-
mogeneous if h(t) 6= 0. We say that (1.1) is autonomous if f(t, xt) = g(xt)
where g does not depend on t, otherwise we say that (1.1) is nonautonomous.
The DDE (1.1) includes many classes of equations such as ODE if r = 0,
in fact, in this case xt is defined on the interval consisting of the single point
0 and xt = xt(0) = x(t). It includes also differential-difference equations of
the form:
x˙(t) = f(t, x(t), x(t− r1), ..., x(t− rm)) (1.4)
where 0 ≤ ri ≤ r for i = 0, ...,m. Here f is a function of nm + 1 real
variables and we say that there are m delays in the equation, each less than
r. The delays ri may also depend on the time t. Finally, DDE (1.1) includes
integro-differential equations:
x˙(t) =
∫ 0
−r
g(t, x(t), θ, xt(θ))dθ (1.5)
where g is a function of 2n+ 2 variables.
We observe that, if we assume f continuous, finding a solution of (1.1)
through (σ, ϕ) ∈ R× C is equivalent to solving the integral equation:{
x(t) = ϕ(0) +
∫ t
σ f(s, xs)ds t ≥ 0
xσ = ϕ
(1.6)
Theorems of existence and uniqueness of solutions hold and are more or less
analogous to the corresponding results for ODE.
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Theorem 1.1.1. Suppose Ω is an open subset in R×C and f is continuous
in Ω. If (σ, ϕ) ∈ Ω, then there is a solution of (1.1) through (σ, ϕ).
Definition 1.1.1. We say that f(t, ϕ) is Lipschitz in ϕ in a compact subset
K in R× C if there is a constant k > 0 such that ∀ (t, ϕi) ∈ K (i = 1, 2)
|f(t, ϕ1)− f(t, ϕ2)| ≤ k|ϕ1 − ϕ2|
Theorem 1.1.2. Suppose Ω is an open subset in R × C, f : Ω → Rn is
continuous and f(t, ϕ) is Lipschitz in ϕ in every compact of Ω. If (σ, ϕ) ∈ Ω,
then there is a unique solution of (1.1) through (σ, ϕ).
Also theorems about continuous dependence on initial values and on
the continuation of solutions hold and are analogous to the corresponding
results for ODE, but in some cases one has to assume that f is completely
continuous.
Theorem 1.1.3. Suppose Ω ⊆ R × C is open, (σ, ϕ) ∈ Ω, f ∈ C(Ω,Rn),
and x is a solution of (1.1) through (σ, ϕ) which exists and is unique on
[σ − r, b], b > σ − r. Let W ⊆ Ω be the compact set defined by
W = {(t, xt) : t ∈ [σ, b]}, and let V be a neighborhood of W on which f is
bounded. If (σk, ϕk, fk), k=1,2,..., satisfies σk → σ, ϕk → ϕ, and |fk −
f |V → 0 as k → ∞, then there is a K such that for k ≥ K each solution
xk = xk(σk, ϕk, fk) through (σk, ϕk) of x˙(t) = fk(t, xt) exists on [σk − r, b]
and xk → x uniformly on [σk − r, b]. (Since all xk may not be defined on
[σk − r, b], by xk → x uniformly on [σk − r, b] we mean that for any ε > 0
there is a k1(ε) such that xk(t), k ≥ k1(ε) is defined on [σk − r + ε, b] and
xk → x uniformly on [σk − r + ε, b].)
Let x be a solution of (1.1) on the interval [σ, a), a > σ. We say that xˆ
is a continuation of x if there is a b > a such that xˆ is defined on [σ − r, b),
coincides with x on [σ − r, a), and x satisfies the equation (1.1) on [σ, b). A
solution x is said noncontinuable if no such continuation exists, that is the
interval [σ, a) is the maximal interval of existence of the solution x. The
existence of a noncontinuable solution is a consequence of Zorn’s lemma.
Theorem 1.1.4. Suppose Ω open in R × C, f : Ω → Rn completely con-
tinuous and let x be a noncontinuable solution of (1.1) on [σ − r, b). Then
for any closed and bounded set U ∈ R × C, U ⊂ Ω, there is a tU such that
(t, xt) 6∈ U for tU ≤ t < b.
The previous theorem says that solutions of equation (1.1) exist for any
time t ≥ σ or become unbounded (with respect to Ω) in finite time and
it gives conditions under which the trajectory (t, x) in R × C of a noncon-
tinuable solution of [σ, b) approaches the boundary of Ω as t → b−. If the
condition that f is completely continuous is not imposed, then it is conceiv-
able that the trajectory {(t, xt) : σ ≤ t < b} itself is a closed bounded subset
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of Ω; that is the curve (t, x(t)) oscillates so badly as a subset of R×Rn that
there are no limit points of (t, xt) in R× C as t→ b−.
Theorem 1.1.5. Suppose that x : [−r, α) → Rn, r > 0, α finite, is an
arbitrary bounded continously diffrentiable function satisfying the property
that x(t) does not approach a limit set as t→ α−. Then there is a continuous
function f : C → Rn such that x is a noncontinuable solution of the DDE(f)
on [−r, α).
The theorem on continuation of solutions states that a noncontinuable
solution of a DDE(f) must leave every bounded and closed set W in the
domain Ω of the equation, supposing that f is completely continuous on Ω.
A continuous function on Ω is not necessarily completely continuous on Ω
if r > 0, that is if C is infinite-dimensional.
The theorem on continuation of solutions does not hold if f is not completely
continuous.
For the ode {
x˙(t) = f(t, xt)
x(0) = x0
(1.7)
if f ∈ Ck, k ≥ 0 then the solution x(t) of (1.7) is itself in the space Ck in its
maximal interval of existence. For the equation (1.1) the same is true only
for some values of t. In the Theorem 1.1.3 were given sufficient conditions
to assure that the solution x(σ, ϕ, f) of a DDE(f) depends continuously on
(σ, ϕ, f). Here we state some results on the differentiability of solutions with
respect to (σ, ϕ, f).
Theorem 1.1.6 (Smoothing property). Let x(t) be the solution of{
x˙(t) = f(t, xt)
xσ = ϕ, ϕ ∈ C, (1.8)
where f ∈ Ck, k ≥ 1 and let I = [σ, tx) be the maximal interval of existence
for x(t). Then x(t) ∈ C l on [σ + lr, tx) for l=0,1,...k.
In other words x(t) is even more regular increasing T . If f ∈ C1, Φ ⊂ C
is a bounded closed set and T (t)Φ ≡ ⋃ϕ∈ΦXt(σ, ϕ) is a bounded set for
t ≥ σ + r, then T (t)Φ is compact as t ≥ σ + r.
If Ω is open in R × C, let Cp(Ω,Rn), p ≥ 0 be the space of functions
mapping Ω in Rn and bounded continuously differentiable up to order p with
respect to ϕ on Ω. The space Cp(Ω,Rn) becomes a Banach space with the
norm of supremum over all derivatives up to order p.
Next theorem follows from contraction principle in Banach spaces.
Theorem 1.1.7. If f ∈ Cp(Ω,Rn), p ≥ 1, then the solution x(σ, ϕ, f)(t) of
DDE(f) through (σ, ϕ) is unique and continuously differentiable with respect
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to (ϕ, f) for t in a compact set in the domain of x(σ, ϕ, f). Moreover, for any
t ≥ σ the derivative of x with respect to ϕ: Dϕx(σ, ϕ, f)(t) is a linear oper-
ator from C to Rn, Dϕx(σ, ϕ, f)(σ) = I, the identity, and Dϕx(σ, ϕ, f)ψ(t)
for any ψ ∈ C satisfies the linear variational equation:
y(t) = Dϕf(t, xt(σ, ϕ, f))yt.
Moreover, for any t ≥ σ, Dfx(σ, ϕ, f)(t) is a linear operator from Cp(Ω,Rn)
in Rn, Dfx(σ, ϕ, f)(σ) = 0 and Dfx(σ, ϕ, f)g(t) for g ∈ Cp(Ω,Rn) satisfies
the linear variational equation:
z˙(t) = Dϕf(t, xt(σ, ϕ, f))zt + g(t, xt(σ, ϕ, f)).
1.2 Dynamical systems and invariance
For autonomous ODEs, bounded solutions have nonempty, compact, con-
nected an invariant Ω-limit sets. Similar results hold also for DDEs.
Definition 1.2.1 (Process). Let X be a Banach space, u : R×X×R+ → X
a given mapping and let us define U(σ, t) : X → X for σ ∈ R, t ∈ R+ by
U(σ, t)x = u(σ, x, t). A process on X is a mapping u : R × X × R+ → X
satisfying the following properties:
(i) u is continuous;
(ii) U(σ,0)= I;
(iii) U(σ+s,t)U(σ,s)= U(σ, s+t).
A process u is said p-periodic, p > 0 if U(σ+p,t)=U(σ,t) for σ ∈ R, t ∈ R+.
Suppose f : R×C → Rn is completely continuous and let x(σ, ϕ) be the
solution of DDE(f):
x˙(t) = f(t, xt), xσ = ϕ. (1.9)
We assume that x is uniquely defined for t ≥ σ. Theorem 1.1.3 implies that
x(σ, ϕ)(t) is continuous in σ, ϕ, t for σ ∈ R, ϕ ∈ C e t ≥ σ. Define
u(σ, ϕ, τ) = xσ+τ (σ, ϕ), (σ, ϕ, τ) ∈ R× C × R+,
then u is a process on C. Moreover, let T (t, σ) be the solution operator for
(1.9) defined by:
T (t, σ)ϕ = xt(σ, ϕ);
then U(σ, τ) = T (σ + τ, σ), where U(σ, τ)ϕ = u(σ, ϕ, t).
We will say that u(σ, ϕ, τ) is the process generated by the DDE(f).
If f(σ+p, ϕ) = f(σ, ϕ) p > 0 ∀(σ, ϕ) ∈ R×C then the process generated
by the DDE(f) is p-periodic.
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Definition 1.2.2. A process is said a (continuous) dynamical system, or
an autonomous process, if U(σ, t) is indipendent by σ; that is if
T (t) = U(0, t), t ≥ 0,
then T(t)x is continuous for (t, x) ∈ R+ ×X,
T (0) = I, T (t+ τ) = T (t)T (τ), t, τ ∈ R+.
We also call T (t), t ≥ 0 a (continuous) dynamical system.
If S : X → X is a continuous map, the family {Sk, k ≥ 0} of iterates
of S is said a discrete dynamical system. If u is a p-periodic process and
S = U(0, p), then Sk = U(0, kp). We refer to this discrete dynamical system
as the discrete dynamical system generated by the map of the p-periodic
process.
In a process u(σ, x, t) can be considered as the state of the system at
time σ + t when initial state at time σ is x.
Definition 1.2.3. Suppose that u is a process in X. The trajectory τ+(σ, x)
through (σ, x) ∈ R×X is:
τ+(σ, x) =
{
(σ + t, U(σ, t)x) : t ∈ R+} ⊂ R×X.
The orbit γ+(σ, x) through (σ, x) is:
γ+(σ, x) =
{
U(σ, t)x : t ∈ R+} ⊂ X.
If H is a subset of X, then
τ+(σ,H) =
⋃
x∈H
τ+(σ, x), γ+(σ,H) =
⋃
x∈H
γ+(σ, x).
A point C ∈ X is said an equilibrium (or critical) point of a process u if
U(σ, t)C = C for t ∈ R+. If there is σ ∈ R, p > 0, x ∈ X such that
U(σ, t+ p)x = U(σ, t)x for any t ∈ R+ then τ+(σ, x) is said p-periodic.
If u is a process p-periodic on X, then the trajectory τ+(σ + kp, x) for
any integer k ∈ R is the traslated along reals of kp of the trajectory τ+(σ, x).
The orbits satisfy γ+(σ + kp, x) = γ+(σ, x) for any integer k ∈ R . If u is a
dynamical system on X then τ+(σ + s, x) is the traslated by s of τ+(σ, x)
for any s ∈ R and γ+(σ, x) = γ+(0, x) for any s ∈ R. In this last case we
simply write γ+(x) for orbits.
Lemma 1.2.1. For a continuous dynamical system, a trajectory is p-periodic
if and only if the corresponding orbit is a closed curve. For a p-periodic pro-
cess u, a trajectory through (σ, x) is kp-periodic for a positive integer k if
and only if T kx = x where T = U(σ, p).
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Lemma 1.2.2. Let {T (t) : t ≥ 0} be a dynamical system on X. If there are
sequences {xn} ⊆ X, {ωn} ⊆ (0,∞) satisfying T (ωn)xn = xn, ωn → 0
when n→∞ and some subsequence of {xn} converges to x0, then x0 is an
equilibrium point.
Definition 1.2.4. Suppose that u is a process on X. A point y ∈ X is said
to be in the ω-limit set ω(σ, x) of an orbit γ+(σ, x) if there is a sequence
tn → ∞ as n → ∞ such that U(σ, tn)x → y as n → ∞. A point y ∈ X is
said to be in the α-limit set α(σ, x) of an orbit γ−(σ, x) =
⋃
t≤0 U(σ, t)x if
U(σ, t) is uniquely defined for t ≤ 0 and there is a sequence tn → −∞ as
n→∞ such that U(σ, tn)x→ y as n→∞.
Equivalently we have:
ω(σ, x) =
⋂
t≥0
⋃
τ≥t
U(σ, τ)x, (1.10)
α(σ, x) =
⋂
t≤0
⋃
τ≤t
U(σ, τ)x, (1.11)
For any subset H ⊆ X we define ω- and α-limit sets of H, ω(σ,H), α(σ,H)
by replacing x byH in (1.10), (1.11) respectively. If
{
T k, k ≥ 0} is a discrete
dynamical system of X, and H ⊆ X, then the ω-limit set of H is defined as:
ω(H) =
⋂
j≥0
⋃
n≥j
TnH,
and the α-limit set of H is defined as:
α(H) =
⋂
j≤0
⋃
n≤j
TnH,
provided that TnH is well defined for any n ≤ 0.
For autonomous DDE(f),{
x˙(t) = f(xt),
xσ = ϕ,
we have that ω(σ, x) = ω(x) is independent on σ. So y ∈ ω(x) (resp. α(x))
if and only if there is a sequence tn →∞ (resp. −∞) as n→∞ such that
lim
n→∞xtn(σ, ϕ) = y. (1.12)
Definition 1.2.5. If u is a process on X, then an integral of the process on R
is a continuous function y : R→ X such that for any σ ∈ R, τ+(σ, y(σ)) =
{(σ + t, y(σ + t)) : t ≥ 0}. An integral y is an integral through (σ, x) ∈ R×X
if y(σ) = x. An integral set on R is a set M in R × X such that for any
(σ, x) ∈ M there is an integral y on R through (σ, x) and (s, y(s)) ∈ M for
s ∈ R. For any σ ∈ R, let Mσ = {x ∈ X : (σ, x) ∈M}.
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Definition 1.2.6. If {T (t), t ≤ 0} is a dynamical system on X, then a set
Q ⊆ X is said invariant if T (t)Q = Q for t ≥ 0. This is equivalent to saying
that through every point x ∈ Q there is an integral y through (0, x) such that
y(s) ∈ Q, s ∈ R.
Definition 1.2.7. If u is a dynamical system on X, then a subset Q ⊆ X
is said to be a positively (negatively) invariant set for u if for any point
x ∈ Q, γ+(0, x) ⊂ Q (if U(σ, t) is well defined for t ≤ 0 and γ−(0, x) =
{U(σ, t)x : t ≤ 0} ⊂ Q).
Q is said an invariant set of u if T (t)Q ≡ ⋃x∈Q T (t)x = Q for every t ≥ 0.
Theorem 1.2.3. If an autonomous DDE(f) generates a dynamical system
and γ+(ϕ) is a bounded orbit, then ω(ϕ) is nonempty, compact, connected
and invariant. If H ⊆ C is connected and γ+(H) is bounded the same
conclusion is true for ω(H).
1.3 Stability theory
1.3.1 Stability and maximal invariant sets
Definition 1.3.1. For a given process u on X and a given σ ∈ R, we say
a set M ⊂ R × X attracts a set H ⊂ X in σ if, for any ε > 0, there is a
t0(ε,H, σ) such that (σ + t, U(σ, t)H) ⊂ B(M, ε) for t ≥ t0(ε,H, σ). If M
attracts a set H in σ for every σ ∈ R, we say M attracts H.
Definition 1.3.2. For a given process u on X and a given σ ∈ R, we say
a set M ⊂ R × X is stable in σ if, for any ε > 0, there is a δ(ε, σ) > 0
such that (σ, x) ∈ B(M, δ(ε, σ)) implies that (σ + t, U(σ, t)x) ∈ B(M, ε) for
t ≥ 0. The set M is said stable if it is stable in σ for any σ ∈ R. The set
M is said unstable if it is not stable. The set M is said uniformly stable if
it is stable and the number δ in the definition is independent on σ. The set
M is said asymptotically stable in σ if it is stable in σ and there is a ε0(σ)
such that (σ + t, U(σ, t)) → M as t→∞ for (σ, x) ∈ B(M, ε0(σ)). The set
M is said uniformly asymptotically stable if it is uniformly stable and there
is a ε0 > 0 such that for every η > 0, there is t0(η, ε0) with the property
that (σ + t, U(σ, t)) ∈ B(M,η) for t ≥ t0(η, ε0) and for every x such that
(σ, x) ∈ B(M, ε0).
If a process is generated by an ODE in Rn, then M ⊂ R× Rn stable in
a given σ ∈ R implies that M is stable in every σ ∈ R, that is M is stable.
This result does not hold for more general processes, in particular it is not
true for DDE.
It is difficult to determine when stability in σ is equivalent to stability.
From a practical point of view, it is not so relevant to consider systems that
are stables in σ but there are not stables. Therefore this weaker concept
will not be discussed in detail.
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Suppose now that u is a p-periodic process, K ⊂ X is a compact set,
and that M ⊂ R × K attracts compact sets of X. For any σ ∈ R, let us
consider the discrete dynamical system
{
Uk(σ, p), k ≥ 0}. For this discrete
system K attracts compact sets of X and we can define:
Jσ =
⋂
n≥0
Un(σ, p)K, σ ∈ R. (1.13)
Jσ is indipendent from K. If J ⊂ R×X is defined by:
J =
⋃
σ∈R
(σ, Jσ), (1.14)
then J is an invariant set for the process u and
Jσ def= {x ∈ X : (σ, x) ∈ J } = Jσ
is compact.
⋃
σ Jσ also is compact in X.
Theorem 1.3.1. Suppose that u is a p-periodic process on X, and there is
a compact set K ⊂ X such that R ×K attracts compact sets of X, and let
J ⊂ R×X be defined by (1.14). Then the following conclusion hold:
(i) J is connected;
(ii) J is independent of K, and it is a nonempty invariant set with Jσ
compact, and J is maximal with respect to this property;
(iii) J is stable;
(iv) For any compact set H ⊂ X, J attracts H.
Theorem 1.3.2. For a p-periodic, linear, nonhomogeneous DDE, the exis-
tence of a bounded solution for t ≥ 0 implies the existence of a p-periodic
solution.
Suppose f : R× C → Rn continuous and consider the DDE(f) (1.1).
We will suppose that function f is completely continuous and that it satifsfies
sufficient conditions of regolarity to assure that solution x(σ, ϕ)(t) through
(σ, ϕ) is continuous in (σ, ϕ, t) in the domain of the function.
Definition 1.3.3. Suppose f(t, 0) = 0 ∀t ∈ R.
- The solution x = 0 of equation (1.1) is said stable if for any σ ∈ R, ε >
0,there is a δ = δ(ε, σ) such that ϕ ∈ B(0, δ) implies xt(σ, ϕ) ∈ B(0, ε)
for t ≥ σ.
- The solution x = 0 of equation (1.1) is said asymptotically stable if it is
stable and there is a b0 = b0(σ) > 0 such that ϕ ∈ B(0, b0) implies
x(σ, ϕ)(t)→ 0 if t→∞.
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- Solution x = 0 is said uniformly asymptotically stable if the number δ in
the definition is independent to σ.
- Finally it is said uniformly asymptotically stable if it is uniformly stable
and there is a b0 > 0 such that for any η > 0 there is a t0(η) such that
ϕ ∈ B(0, b0) implies xt(σ, ϕ) ∈ B(0, η) for t ≥ σ+ t0(η) for any σ ∈ R.
If y(t) is a generic solution of equation (1.1), then y is said to be stable if
solution z = 0 of equation
z˙(t) = f(t, zt + yt)− f(t, yt)
is stable and similarly are defined other concepts.
Lemma 1.3.3. If there is a ω > 0 such that f(t+ ω, ϕ) = f(t, ϕ) for every
(t, ϕ) ∈ R × C, then solution x = 0 is stable (asymptotically stable) if and
only if it is uniformly stable (uniformly asymptotically stable).
Definition 1.3.4. A solution x(σ, ϕ) of a DDE(f) is bounded if there is
a β(σ, ϕ) such that |x(σ, ϕ)(t)| < β(σ, ϕ) for t ≥ σ − r. Solutions are
uniformly bounded if for any α > 0, there is a β = β(α) > 0 such that for
any σ ∈ R, ϕ ∈ C and |ϕ| ≤ α, we have |x(σ, ϕ)(t)| ≤ β(α) for all t ≥ σ.
1.3.2 The method of Liapunov functionals
In this section we give sufficient conditions to stability and instability of
solution x = 0 of equation (1.1) generalizing the method of Liapunov by
which we may obtain stability results, and often global ones, in the context
of DDE(f):
x˙(t) = f(t, xt), (1.15)
where f : R× C → Rn is completely continuous and f(t, 0) = 0.
Let V : R × C → Rn be continuous and x(σ, ϕ) be the solution of (1.15))
through (σ, ϕ). We denote:
V˙ = V˙ (t, ϕ) = lim sup
h≥0+
1
h
[V (t+ h, xt+h(t, ϕ))− V (t, ϕ)].
Next theorem contains general stability results of the method of Liapunov
functionals.
Theorem 1.3.4. Let u(s), v(s), w(s): R+ → R+ be continuous and non-
decreasing, u(s) > 0, v(s) > 0 for s > 0 and u(0)=v(0)=w(0)=0. The
following statements are true:
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(i) If there is a V : R× C → R such that
u(|ϕ(0)|) ≤ V (t, ϕ) ≤ v(‖ϕ‖),
V˙ (t, ϕ) ≤ −w(|ϕ(0)|),
then x = 0 is uniformly stable.
(ii) If, in addition to (i), lims→+∞ u(s) = +∞, then solutions of (1.15) are
uniformly bounded (that is, for any α > 0, there is a β = β(α) > 0
such that, for all σ ∈ R, ϕ ∈ C, ‖ϕ‖ ≤ α we have |x(σ, ϕ)(t)| ≤ β for
all t ≥ σ.)
(iii) If, in addition to (i), w(s) > 0 for s > 0, then x=0 is uniformly
asymptotically stable.
We say that V : R×C → R is a Liapunov functional for equation (1.15)
if it satisfies Theorem 1.3.4-(i).
Next Theorem gives sufficient conditions to instability of solution x = 0
of equation (1.15).
Theorem 1.3.5. Suppose that V (ϕ) is a scalar functional completely con-
tinuous on C and that there is a γ > 0 and an open set U in C such that:
(i) V (ϕ) > 0 on U, V (ϕ) = 0 on the boundary of U; 0 ∈ ¯U ∩B(0, γ);
(ii) zero belongs to the closure of U ∩B(0, γ),
(iii) V (ϕ) ≤ u(|ϕ(0)|) on U ∩B(0, γ);
(iv) V˙−(ϕ) ≥ w(|ϕ(0)|) for (t, ϕ) ∈ [0.∞)× U ∩B(0, γ), where
V˙− ≡ lim inf
h→0+
1
h
[V (xt+h(t, ϕ))− V (ϕ)],
and where u(s), w(s) are continuous, positive and increasing for s > 0,
u(0) = w(0) = 0. Then x = 0 is unstable.
We consider now autonomous systems:
x˙(t) = f(xt), (1.16)
where f : C → Rn is completely continuous and solutions of (1.16) are
unique and depend continuously on initial conditions.
For autonomous ODEs Liapunov-La Salle Theorem is a very useful tool
to state sufficient conditions of (global) stability of equilibrium points or of
attractors.
A similar Theorem holds also in the context of DDE.
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For a continuous functional V : C → R, we define:
V˙ (ϕ) = lim sup
h→0+
1
h
[V (xh(ϕ))− V (ϕ)],
the derivative of V along the solution of (1.16). In order to state the
Liapunov-La Salle type theorem for DDE(f) (1.16), we need the following
definition:
Definition 1.3.5. We say that V : C → R is a Liapunov functional on a
set G in C for equation (1.16) if it is continuous on G¯ and V˙ ≤ 0 on G. We
also define
E =
{
ϕ ∈ G¯ : V˙ (ϕ) = 0
}
,
M= the largest set in E invariant with respect to (1.16).
We state now the Liapunov-La Salle type theorem for DDE(f) (1.16).
Theorem 1.3.6. If V is a Liapunov functional on G and xt(ϕ) is a bounded
solution of (1.16) that stays in G, then ω(ϕ) ⊂ M ; that is, xt(ϕ) → M as
t→ +∞.
Corollary 1.3.7. If V is a Liapunov functional on Ul = {ϕ ∈ C : V (ϕ) < l}
for equation (1.16) and there is a constant K = K(l) such that ϕ in Ul
implies that |ϕ(0)| < K, then for ϕ ∈ Ul, ω(ϕ) ⊂M .
Corollary 1.3.8. Suppose that a(·) and b(·) are continuous and nonnega-
tive, that a(0) = b(0) = 0, and lims→+∞ a(s) = +∞, and that V : C → R is
continuous and satisfies:
V (ϕ) ≥ a(|ϕ(0)|), V˙ (ϕ) ≤ −b(|ϕ(0)|).
then solution x = 0 of equation (1.16) is uniformly stable, and every solution
is bounded. If, in addition, b(s) > 0 for s > 0, then x = 0 is globally
asymptotically stable; that is every solution of (1.16) converges to x = 0 as
t→ +∞.
Theorem 1.3.9. Suppose that 0 belongs to the closure of an open subset U
in C and that N is an open neighborhood of 0 in C. Assume that:
(i) V is a Liapunov function on G = N ∩ U .
(ii) M ∩G is either the empty set or zero .
(iii) V (ϕ) < η on G when ϕ 6= 0.
(iv) V (0) = η and V (ϕ) = η when ϕ ∈ ∂G ∩N .
If N0 is a bounded neighborhood of zero properly contained in N, then ϕ 6= 0
in G ∩N0 implies there exists a τ such that xτ (ϕ) ∈ ∂N0.
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1.3.3 Razumikhin theorems
In the previous section, sufficient conditions for stability of a DDE were
given in terms of the rate of change of functionals along solutions. The
use of functionals is a natural generalization of the method of Liapunov for
ODEs.
On the other hand, it is much simpler to handle functions than functionals,
so it is natural to explore the possibility of using the rate of change of a
function in Rn to determine sufficient conditions for stability. Results in
this direction are generally referred to as theorems of Razumikhin type.
If v : Rn → Rn is a given positive function, continuously differentiable,
then the derivative of v along a DDE(f) is given by:
v˙(x(t)) =
∂v(x(t))
∂x
f(xt). (1.17)
In order for v˙ to be nonpositive for all initial data, we will be forced to
impose very severe restrictions on f(ϕ). In fact, the point ϕ(0) must play a
dominant role and, therefore, the results will apply only to equations that
are very similar to ODEs.
But we may see that it is not necessary to require that v˙ is nonpositive
for every initial condition in order to have stability. In fact if a solution
of DDE(f) begins in a ball and is to leave this ball at some time t, then
|xt| = |x(t)|; that is |x(t+ θ)| ≤ |x(t)| for all θ ∈ [−r, 0]. Consequently, one
needs only consider initial data satisfying this latter property. This is the
basic idea exploited in this section.
If V : R×Rn → R is a continuous function, then V˙ (t, ϕ(0)), the derivative
of V along solutions of DDE(f) is defined by:
V˙ (t, ϕ(0)) = lim sup
h→0+
1
h
[V (t+ h, x(t, ϕ)(t+ h))− V (t, ϕ(0))]
where x(t, ϕ) is the solution of DDE(f) through (t, ϕ).
Theorem 1.3.10. Suppose f : R × C → Rn maps R×(bounded sets of C)
into bounded sets of Rn and consider the DDE(f). Suppose u, v, w : R+ →
R+ are continuous, nondescreasing functions u(s), v(s) positive for s > 0,
u(0) = v(0) = 0, v strictly increasing. If there exists a continuous function
V : R× Rn → R such that
u(|x|) ≤ V (t, x) ≤ v(|x|), t ∈ R, x ∈ Rn, (1.18)
and
V˙ (t, ϕ(0)) ≤ −w(|ϕ(0)|) se V (t+ θ, ϕ(θ)) ≤ V (t, ϕ(0)), (1.19)
for θ ∈ [−r, 0], then solution x = 0 of DDE(f) is uniformly stable.
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Theorem 1.3.11. Suppose all the conditions of Theorem 1.3.10 are satisfied
and in addition w(s) > 0 for s > 0. If there exists a continuous nondecreas-
ing function p(s) > s for s > 0 such that condition (1.18) is strengthened
in:
V˙ (t, ϕ(0)) ≤ −w(|ϕ(0)|) if V (t+ θ, ϕ(θ)) ≤ pV (t, ϕ(0)), (1.20)
for θ ∈ [−r, 0], then solution x = 0 of DDE(f) is uniformly asymptotically
stable. If u(s)→∞ as s→∞, then solution x = 0 is also a global attractor
for DDE(f).
Theorem 1.3.12. Suppose f : R × C → Rn maps R×(bounded sets of C)
into bounded sets of Rn and consider DDE(f). Suppose u, v, w : R+ → R+
are continuous nonincreasing functions, u(s) → ∞ as s → ∞. If there is
a continuous function V : R × Rn → R and a continuous nondecreasing
function p : R+ → R+, p(s) > s for s > 0 and a constant H ≥ 0 such that:
u(|x|) ≤ V (t, x) ≤ v(|x|) t ∈ R, x ∈ Rn
and V˙ (t, ϕ) ≤ −w(|ϕ(0)|). If |ϕ(0)| ≥ H, V (t+θ, ϕ(θ)) < p(V (t, ϕ(0))), θ ∈
[−r, 0], then solutions of DDE(f) are uniformly ultimately bounded.
1.4 Periodic solutions of autonomous equations -
Hopf bifurcations.
Many observations realised that real world systems that have a stable steady
state may lose the stability and begins to oscillate first with small amplitudes
and then wilder as a parameter of the system (for example the delay lenght)
is varied. In most cases as the amplitude of oscillation get larger these
systems collapse, break down or just remain oscillatory.
The mathematical modeling of such phenomena leads to systems of dif-
ferential equations depending on a parameter and having isolated equilib-
rium point that is stable if the parameter belongs to some interval but loses
its stability as the parameter crosses the boundary of this interval. At the
same time, in the neighbourhood of the critical value of the parameter where
the stability of the equilibrium is lost, small amplitude periodic solutions oc-
cur. The appearance of small amplitude periodic solutions simultaneously
with the loss of stability of an equilibrium is a generic phenomenon in sys-
tems depending on a parameter and having an isolated equilibrium for every
parameter value. The important thing is that the linearization of the system
at the equilibrium point must have a pair of complex conjugated eigenvalues
(depending on the parameter), and at the critical value of the parameter this
pair has to cross from the left-hand half plane to the right-hand half in the
complex plane and has to do it with non-zero speed.
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In this section we will indicate a procedure to determine periodic so-
lutions of some classes of autonomous DDE. In particular we give special
attention to one of the simplest methods in which nonconstant periodic so-
lutions of autonomous equations can arise: Hopf bifurcations. As we know,
even in ODE case one of the most simpler methods in which a nonconstant
periodic solution can occur is via Hopf bifurcations. It happens when a real
parameter α passes through a critical value α0 and two eigenvalues cross
the imaginary axis from left to right. Hopf bifurcation theorem ensures the
local existence of emerging periodic solutions.
Going back to DDE theory we consider a one-parameter family of the form:
x˙(t) = F (α, xt) (1.21)
where F (α,ϕ) has continuous first and second derivatives in α, ϕ for α ∈ R,
ϕ ∈ C, and F (α, 0) = 0 for every α. We define L : R× C → Rn as:
L(α)ψ = DϕF (α, 0)ψ (1.22)
where DϕF (α, 0) is the derivative of F (α, ϕ) with respect to ϕ in ϕ = 0 and
we define:
f(α, ϕ) = F (α, ϕ)− L(α)ϕ. (1.23)
We also suppose:
(H1) The linear DDE(L(0)) has a simply purely imaginary characteristic
root: λ0 = iν0 6= 0 and all characteristic roots λj 6= λ0, λ¯0 satisfy
λj 6= mλ0 for any integer m.
Since L(α) is continuously differentiable in α, there is a α0 > 0 and a simple
characteristic root λ(α) of the DDE(L(α)) that has a continuous derivative
λ′(α) in α for |α| < α0. Suppose:
(H2) Reλ′(0) 6= 0.
We will show that (H1) and (H2) imply there are nonconstant periodic
solutions of equation (1.21) for α small that have period close to 2pi/ν0.
Before stating this result precisely, we have to introduce some notations.
By taking a0 sufficiently small, we may assume Imλ(α) 6= 0 for |α| < α0
and obtain a function ϕα ∈ C that is continuously differentiable in α and
that is a basis for the solutions of the DDE(L(α)) corresponding to λ(α).
The functions:
(Reϕα, Imϕα)
def
= Φα
form a corresponding basis for the characteristic roots λ(α), λ¯(α). Similarly
we obtain a basis Ψα for the adjoint equation with (Ψα,Φα) = I.
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If we decompose C by (λ(α), λ¯(α)) as C = Pα ⊕ Qα, then Φα is a basis of
Pα. We know that
Φα(θ) = Φα(0)eB(α)θ, −r ≤ θ ≤ 0, (1.24)
and the eigenvalues of the 2×2 matrix B(α) are λ(α) and λ¯(α). By a change
of coordinates and redefining parameter α we may assume that:
B(α) = v0B0 + αB1(α) (1.25)
B0 =
[
0 1
−1 0
]
, B1(α) =
[
1 γ(α)
−γ(α) 1
]
where γ(α) is continuously differentiable on 0 ≤ |α| < α0
We can now state the Hopf bifurcation theorem.
Theorem 1.4.1. Suppose F (α, ϕ) has continuous first and second deriva-
tives with respect to α, ϕ, F (α, 0) = 0 for all α and hypothesis (H1) and
(H2) are satisfied. Then there are constants a0 > 0, α0 > 0, δ0 > 0, func-
tions α(a) ∈ R, ω(a) ∈ R, and an ω(a)-periodic function x∗(a), with all
functions being continuously differentiable in a for |a| < a0, such that x∗(a)
is a solution of equation (1.21) with:
x∗0(a)
Pα = ϕα(a)y
∗(a), x∗0(a)
Qα = z∗0(a)
where y∗(a) = (a, 0)T + o(|a|), z∗0(a) = o(|a|) as |a| → 0. Furthermore, for
|α| < α0, |ω − (2pi/ν0)| < δ0, every ω-periodic solution of equation (1.21)
with |xt| < δ0 must be of this type except for a translation in phase.
1.5 Characteristic equation analysis
Now we have to introduce methods of analysis that will be utilised in chap-
ters 4 and 5 of this work to study qualitative properties of a model of tumor-
immune system interaction with delay. In particular we are interested to
analysis of stability of equilibrium points and to possible occurrence of Hopf
bifurcations and oscillatory dynamics arising from them. Therefore in this
section we will see how to handle this problem both for equations with dis-
crete delay, that is of the form:
x˙(t) = f(t, x(t), x(t− r1), ..., x(t− rm)),
and in the case of distributed delay, that is for integro-differential equations
of the form:
x˙(t) =
∫ t
−∞
k(t− θ)G(x(θ))dθ,
where integration kernel is choosen of a specific type to permit a strong sim-
plification in qualitative study that otherwise may result very complicated.
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Most studies on delay differential equations start from the local stability
analysis of some special solutions. The standard approach is to analyze the
stability of the linearized equations about the special solution. Stability of
the zero solution depends on the locations of the roots of the associated
characteristic equation.
If delays are finite, characteristic equations are functions to delay and so
are roots of these equations. By changing the value of the delay, stability of
solutions can also change. Such phenomena are often referred to as stability
switches.
In this section the stability of DDE is referred to as the stability of its
zero solution.
We will consider the following equation:
n∑
k=0
ak
dk
dtk
x(t) +
n∑
k=0
bk
dk
dtk
x(t− τ) = 0, (1.26)
we know that if the associated characteristic equation has only roots with
negative real part, and if all roots are uniformly bounded away from the
imaginary axis, then the zero solution of (1.26) is uniformly asymptotically
stable. So, stability analysis reduces to determine conditions under which
every root of
n∑
k=0
akλ
k + (
n∑
k=0
bkλ
k)e−λτ = 0, (1.27)
lies in the left half of the complex plane and is uniformly bouded away from
the imaginary axis. We denote:
P (λ) =
n∑
k=0
akλ
k, Q(λ) =
n∑
k=0
bkλ
k.
And in addition we assume, without loss of generality an = 1. It holds:
Theorem 1.5.1. If |bn| > 1, then for any τ > 0, there is an infinite number
of roots of
P (λ) +Q(λ)e−λτ = 0,
with positive real parts.
Consequently we have
Theorem 1.5.2. If |bn| > 1, then the trivial solution of (1.26) is unstable
for every τ > 0.
Furthermore:
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Theorem 1.5.3. Let f(λ, τ) = λn + αλne−λτ + g(λ, τ), where g(λ, τ) is an
analytic function. Assume |α| > 1, and
lim
Reλ>0, |λ|→∞
1
λn
g(λ, τ) = 0
Then for any τ > 0, there is an infinite number of roots of f(λ, τ) = 0 whose
real parts are positive. In fact there is a sequence {λj} of roots of f(λ, τ) = 0
such that |λj | → ∞ and limj→∞Reλj = 1τ ln |α| > 0, when τ > 0.
Theorem 1.5.4. Let f(λ, τ) = λn + g(λ, τ), where g(λ, τ) is an analytic
function. Assume
α = lim sup
Reλ>0, |λ|→∞
|λ−ng(λ, τ)| < 1
Then, as τ varies, the sum of the multiplicities of roots of f(λ, τ) = 0 in
the open right half-plane can change only if a root appears on or crosses the
imaginary axis.
1.5.1 Discrete delay- second order equations
Let us discuss now the case of second order equations, since for study the
model that we will analyze in this work, we have to use equations of this
type. The general form of equation is:
d2x(t)
dt2
+α
d2x(t− τ)
dt2
+a
dx(t)
dt
+ b
dx(t− τ)
dt
+ cx(t)+dx(t− τ) = 0, (1.28)
where τ, α, a, b, c, d are real constants. The corresponding characteristic
equation is:
λ2 + αλ2e−λτ + aλ+ bλe−λτ + c+ de−λτ = 0. (1.29)
We see that if |α| > 1 trivial solution is always unstable for τ > 0, therefore
we will assume |α| < 1.
Suppose λ = iω, ω > 0 is a root of (1.29) for some τ . Assume:
(1) c+ d 6= 0, that implies ω 6= 0, we have:
c− ω2 + bωsinωτ + (d− αω2)cosωτ = 0,
aω + bωcosωτ − (d− αω2)sinωτ = 0. (1.30)
Hence:
(1− α2)ω4 + (a2 − b2 + 2dα− 2c)ω2 + c2 − d2 = 0. (1.31)
whose roots are
ω2± =
1
2(1− α2)−1
{
(b2 + 2c− 2dα− a2)± [(b2 + 2c− 2dα− a2)2
−4(1− α2)(c2 − d2)]1/2} .
(1.32)
If c2 ≤ d2, then there is only one imaginary solution λ = iω+, ω+ > 0.
if c2 > d2 there are two imaginary solutions λ± = iω± with ω+ > ω− > 0,
provided that the following statements hold:
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1. b2 + 2c− 2dα− a2 > 0;
2. (b2 + 2c− 2dα− a2)2 > 4(1− α2)(c2 − d2),
and no such solutions otherwise.
Now we have to determine the sign of the derivative of Reλ(τ) at the
points where λ(τ) is purely imaginary.
Assume a2 + b2 + (d− αc)2 6= 0 which guarantees that λ = iω is simple.
For convenience, we study (dλ/dτ)−1. We have:
(
dλ
dτ
)−1 =
(2λ+ a)eλ + b+ 2αλ
λ(αλ2 + bλ+ d)
− τ
λ
,
and
eλτ = −αλ
2 + bλ+ d
λ2 + aλ+ c
. (1.33)
With easy calculations we obtain:
sign(
dRe
dλ
)λ=iω = sign(a2 + 2αd− 2c− b2 + 2ω2(1− α2)).
And this sign is positive for ω2+ and negative for ω
2−.
In the case in which c2 < d2 only one imaginary root exists λ = iω+,
therefore the only crossing of the imaginary axis is from left to right as τ
increases and the stability of the trivial solution can be only be lost and not
recovered.
In the case c2 > d2 crossing from left to right with increasing τ occurs
whenever τ assumes a value corresponding to ω+, and crossing from right to
left occurs for values corresponding to ω−. From equation (1.30) we obtain
the following two sets of values of τ for which there are imaginary roots:
τn,1 =
θ1
ω+
+
2npi
ω+
, (1.34)
where 0 ≤ θ1 < 2pi and
cosθ1 = −abω
2
+ + (c− ω2+)(d− αω2+)
b2ω2+ + (d− αω2+)2
,
senθ1 =
(d− αω2+)aω+ − bω+(c− ω2+)
b2ω2+ + (d− αω2+)2
;
(1.35)
and
τn,2 =
θ2
ω−
+
2npi
ω−
, (1.36)
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where 0 ≤ θ2 < 2pi and
cosθ2 = −abω
2− + (c− ω2−)(d− αω2−)
b2ω2− + (d− αω2−)2
,
senθ2 =
(d− αω2−)aω− − bω−(c− ω2−)
b2ω2− + (d− αω2−)2
;
(1.37)
where n = 0, 1, 2, ....
In the case that c2 < d2 only τ0,1 need to be considered, since if (1.28)
is asymptotically stable for τ = 0, then it remains asymptotically stable
until τ0,1, and it is unstable thereafter. At the value of τ = τ0,1, (1.29) has
pure imaginary roots ±iω+.
In the case c2 > d2 if (1.28) is stable for τ = 0, then it follows that τ0,1 < τ0,2,
since the multiplicity of roots with positive real parts cannot become nega-
tive. We observe that
τn+1,1 − τn,1 = 2pi
ω+
<
2pi
ω−
= τn+1,2 − τn,2.
Therefore, there can be only a finite number of switches between stability
and instability. Moreover, it is easy to see that there exist values of the
parameters that realize any number of such stability switches. However
there exists a value of τ , τ = τˆ , such that in τ = τˆ a stability switch occurs
from stable to unstable, and for τ > τˆ the solution remains unstable.
If (1.28) is unstable for τ = 0, then we can argue similarly. The equation
(1.28) can either be unstable for all τ > 0 or exhibit any number of stability
switches as in the preceding case.
As τ increases, the multiplicity of roots for which Reλ > 0 is increased
by two whenever τ passes through a vaue of τn,1 and it is decreased by two
whenever τ passes through a value of τn,2.
We can summarize the analysis carried out above in a Theorem:
Theorem 1.5.5. In (1.28), assume that |α| < 1, c+d 6= 0 and a2+b2+(d−
αc)2 6= 0. The number of different imaginary roots with positive (negative)
imaginary parts of (1.29) can be zero, one or two only.
1. If there are no such roots, then the stability of the zero solution does
not change for any τ ≥ 0.
2. If there is one imaginary root with positive imaginary part, an unstable
zero solution never becomes stable for τ ≥ 0. If the zero solution is
asymptotically stable for τ = 0, then it is uniformly asymptotically
stable for τ < τ0,1 and it becomes unstable for τ > τ0,1.
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3. If there are two imaginary roots with positive imaginary part, iω+ and
iω−, such that ω+ > ω− > 0, then the stability of the zero solution
can change a finite number of times at most as τ is increased, and
eventually it becomes unstable.
1.5.2 Distributed delay - Linear chain trick
Finally we see how to study a special class of systems with distributed delay.
In fact, often, above all considering models of biological phenomena, it is
more realistic to consider distributed delays instead of discrete ones. With
a distributed delay indeed the present state of the system depends on the
cumulative effects of all past history of state variable.
We will study equations of the form:
x˙(t) + bx(t) + c
∫ t
−∞
ka,m(t− θ)x(θ)dθ = 0 (1.38)
where ka,m is of erlangian type: ka,m(θ) =
amθm−1e−aθ
(m− 1)! . We can rewrite
this equation by introducing m new variables:
x0(t) = x(t),
xl(t) =
∫ t
−∞ ka,l(t− θ)x(θ)dθ, l = 1, ...,m.
(1.39)
We observe that:
ka,l(0) = 0, l > 1; ka,1(0) = a; ka,l(∞) = 0;
hence differentiating under the integral sign we note that new variables
statisfy:
x˙0(t) = −bx0(t)− cxm(t), (1.40)
x˙l(t) = a[xl−1(t)− xl(t)], l = 1, ...,m. (1.41)
The original integro-differential equation (1.38) is then replaced by the
ordinary differential equation (1.40) linking x0(t) and xm(t), and (1.41) con-
stitues the linear chain, that is a sequence of variable each driven by the
previous one. Then every change in x0(t) in propagated down the chain
until it reaches xm(t) that affects the derivative of x0(t). So the delay is
caused by intermediate processes.
In particular the characteristic equation of the system is a polynomial of
order (m+ 1):
(λ+ b)(a+ λ)m + cam = 0,
and the study of the system can be made considering (1.40)-(1.41) and
utilising classical methods of theory of ODEs, for example analysing stability
with Routh-Urwitz criterion.
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Exponentially fading memory The simplest example of distributed de-
lay and the more biologically sound is obtained considering as integration
kernel:
ka,1(θ) = ae−aθ.
In this way the past moments are weighted with a density function exponen-
tially decaying, and the influence of the past is increasing with the decrease
of parameter a.
To analyze the system we have to introduce only one more variable, for
example the equation (1.38) with ka,1 is equivalent to the two equations-
system:
x˙0(t) = −bx0(t)− cx1(t), (1.42)
x˙1(t) = a[x0(t)− x1(t)]. (1.43)
We will analyze our model with an exponentially distributed delay in the
section 5.1.
Memory with a hump Another possible interesting case is obtained
taking as integration kernel the strong erlangian distributed one:
ka,2(θ) = a2θe−aθ.
In this case we have to analyze an ODE system with two more vari-
ables. For example the equation (1.38) with ka,2 is equivalent to the three
equations-system:
x˙0(t) = −bx0(t)− cx2(t), (1.44)
x˙1(t) = a[x0(t)− x1(t)] (1.45)
x˙2(t) = a[x1(t)− x2(t)]. (1.46)
We will analyze our model with a strong erlangian distributed delay in the
section 5.2.
1.6 Delayed logistic equation
As an example of delay differential equation with biological meaning, and
to introduce the importance of delay in biological sytem, we report here
the delayed logistic equation and its derivation in the context of population
dynamics; both with discrete and with distributed delay.
Without considering time delay, the pro capite growth rate of a popula-
tion is often assumed to be logistic, that is:
x˙(t)
x(t)
= r
[
1− x(t)
K
]
; (1.47)
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where x(t) denotes the quantity of the population at time t, K > 0 is the
carrying capacity of the environment and r > 0 is the intrinsic birth rate.
One of the deficiencies of single population models like (1.47) is that
the birth rate is considered to act instantaneously whereas there may be a
time delay to take account of the time to reach maturity, the finite gestation
period and so on.
If we think the gestation period is τ , then the pro capite growth rate
function should carry a time delay τ > 0, which results in:
x˙(t) = rx(t)
[
1− x(t− τ)
K
]
; (1.48)
This says that the regulatory effect depends on the population at an
earlier time, t− τ , rather than that at t.
This equation can be viewed as a particular case of the more general one
in which the delay effect is taken as an average over past populations and
which results in an integrodifferential equation. Thus a more accurate model
can be made considering distributed delay instead of fixed lag delay:
x˙(t) = rx(t)
[
1− 1
K
∫ t
−∞
k(t− s)x(s)ds
]
. (1.49)
where k(t) is the weighting function which says how much emphasis should
be given to the quantity of the population at earlier times to determine the
present effect on resource availability. Practically k(t) will tend to zero for
large negative and positive t and will probably have a maximum at some
representative time T .
Regarding tha analytical study of the delayed equation with discrete
delay, we notice that the character of the solutions of (1.48), and the type of
boundary conditions required are quite different from those of (1.47), and in
general solutions have to be found numerically. Moreover, solutions of (1.48)
can exhibit stable limit cycles for a large range of values of the product rτ
of the birth rate and the delay, whereas solutions of (1.47) cannot exhibit
periodic dynamics.
A direct application ([2]) of the theory exposed previously in this chapter,
yields that the zero solution of (1.48) is asymptotically stable for rτ < pi2
and unstable for rτ > pi2 . Moreover, it is been proved that if
rτ <
37
24
, x(0) > 0, (1.50)
then x(t) → K as t → +∞; and if rτ > pi2 then (1.48) has a nonconstant
periodic solution oscillating with respect to K.
As we said above , in the classical logistic model for a population limit
cycles can not arise; though oscillations are often observed in reality in single
population dynamics. The addition of the delay term, leading to equation
29
1.6
CHAPTER 1. BASIC THEORY OF DELAY DIFFERENTIAL
EQUATIONS
(1.48), permits instead to explain periodic dynamics depending on the value
of delay.
This can be a justification for using delay models to study the dynamics
of single populations which exhibit periodic behaviour.
30
Chapter 2
Tumor-Immune System
Interaction and
Mathematical Models
This chapter aims to point out some basic facts about tumors, immune sys-
tem and tumor-immune system interaction. The problem of mathematical
modeling in cancer research is therefore introduced, followed by a possible
mathematical approach to this issue.
2.1 Tumor, Immune system, and their interaction
Cancer is a family of high-mortality diseases each differing from the other
but all characterized by a remarkable lack of symptoms and by a time course
that can be classified in a broad sense as nonlinear.
The broad outlines of how cancer cells develop and act are now be-
coming clear thanks to the discoveries of geneticists and cell biologists that
have uncovered some basic mechanisms. Cancer is a complex phenomenon
consequent on the breakdown of the normal cellular interaction, control of
replication and induced cellular death.
If a malignant transformation occurs in the genetic control of cellular
replication and interaction it will produce highly proliferative cells that tend
to invade the host organism by rapid proliferation, and subsequent vascu-
larization and metastasis.
Normally the immune system acts as defense against these alterations
and the organism tries to counteract the action of malignant cells by sending
killer cells in the tumor situ. It is the outcome of competition between
malignant and killer cells to decide whether the cancer is rejected or becomes
dominant.
The macroscopic complexity of tumor behavior reflects the intricacy of
its underlying deregulating microscopic biochemical mechanisms, as phe-
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nomenal progress in the field of molecular biology has explained.
Despite these advances, however, challenges remain in detection, as treat-
ment and management of this disease, that include multidisciplinary ap-
proaches in many circumstances.
Immune system produces undifferentiated immune stem cells in the bone
marrow. These cells subsequently differentiate into B- and T- lymphocytes
and are released in the organism as a whole. B and T-cells have a wide
range of antigen receptors, which allow the immune system to identify for-
eign antigens and to distinguish cancer cells.
T-cells perform the tumor elimination, but, to do that, B-cells must
activate them with the help of cytokines (protein hormones produced by
activated lymphocytes which mediate both natural and specific immunity).
When an unknown tissue, an organism or cancer cells appear in the
body, the immune system tries to identify them and, if it succeeds, it tries
to eliminate them. Therefore, the immune system cells are the first host
cells to appear within a tumor.
The immune response begins when the cancer cells are recognized as
being non self and consists of two different interacting responses: the cellular
response and the humoral response. The cellular response is carried out by
T-lymphocytes while the humoral response is related to B-lymphocytes.
Cancer cells are caught by macrophages which can be found in all tissue
of the body and circulate round in the blood stream. An immune response
to specific antigens starts by intensive proliferation of lymphocytes and only
after some time it is accompanied by the production of antibodies and cy-
totoxic activity of T-cells.
When B-cells encounter the antigen they differentiate further into large
cells that proliferate and secrete chemical substances capable of neutraliz-
ing the antigen (antibodies). On the other hand, the T-cells, after further
differentiation in the Thymus, regulate the action of the B-cells by both
activation and inhibition. They are also involved in immune responses that
are directly cell mediated.
This cytotoxic activity is shared by other cellular species of the immune
system, such as macrophages. Macrophages absorb cancer cells, eat them
and release series of cytokines which activate T-helper cells that coordinate
the counterattack. T-helper cells can also be directly stimulated to interact
with antigens.
Helper cells cannot kill cancer cells, but they send urgent biochemical
signals to a special type of T-lymphocytes called Natural killers (NKs). T-
cells begin to multiply and release other cytokines that further stimulate
more T-cells, B-cells or NK-cells.
As the number of B-cells increases, T-helper cells send a signal to start
the process of production of antibodies. Antibodies circulate in the blood
and are attached to cancer cells, which implies that they are more quickly
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engulfed by macrophages or killed by natural killer cells. Like all T-cells,
NK cells, trained to recognize one specific type of an infected cell or a cancer
cell, are lethal.
The immune system comprises many types of lymphocytes which ef-
fectively destroy foreign strange cells after activation. Some lymphocytes
(NKs) even exhibit natural cytotoxicity and do not require activation.
Inflammatory cells are usually the first to be seen. Later, NK-cells, LAK,
T-lymphocytes, B-lymphocytes, non immune cells and vascular system com-
ponents are found in a tumor.
Each of the immune cells type is able to produce a large quantity of
biologically active substances and to absorb them from a medium.
The tumor itself secrets a large number of biologically active substances,
whose effect results in the initiation of leukocyte migration into the tumor.
Tumor may also destroy immune cells that approach it by providing apop-
totic signals.
The competitive interaction between TCs and the IS, involves a consid-
erable number of events and molecules, and as such is extremely complex.
As a consequence, the IS is not able to eliminate a neoplasm in all cases,
which may escape from its control.
Of course, a dynamic equilibrium may also be established, such that the
tumor may survive in a microscopic steady state which is undetectable by
diagnostic equipment.
However, consider a tumor which is constrained by the IS in a micro-
scopic state. Over a long period of time the neoplasm may develop multiple
strategies to circumvent the action of the IS, which in the long term may
allow it to evade immune surveillance and to recommence growing. The
tumor has adapted itself to survive in a hostile environment in which anti
tumor immune response is activated.
Thus, the tumor at an early developmental stage already represents a
rather complex and heterogeneous tissue. These cellular elements are con-
stantly interacting in a dynamical fashion. The dynamics of the anti-tumor
immune response in vivo seems to be very complicated and is not yet well
understood. Spontaneously arising tumors are known to be of low immuno-
genicy and usually grow out of control in a organism.
Nevertheless, at the early stages of tumor growth, the cytolytic effector
cell of the immune system are able to suppress the growth or destroy the
host tumor. On the other hand, tumor growth may be stimulated by some
molecules and immune system cells.
The tumor-immune system interaction involves the stimulation of the
immune response by tumor antigens, but also the tumor induced death of
lymphocytes. When the tumor size increases, it causes a deactivation of
lymphocytes that enter the tumor region. This phenomenon is known as
immunodepression.
In conclusion, the responses of cancer cells to these interactions are char-
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acterized by a considerable evolutionary ability and by mutations that en-
hance their survival in a hostile environment.
2.2 Immunotherapy
The treatment of cancer is one of the most challenging problems in mod-
ern medicine. Cancer is a main cause of death against which surgery and
chemotherapy are unsuccessful in many cases. That is the reason why the
principal efforts are addressed nowadays to search new treatment strategies.
An ideal treatment method should fulfill two basic conditions: it should
destroy cancer cells in the entire body and it should distinguish between
cancerous cells and healthy ones.
Immunotherapy seems to be the method that best fulfills both of these
requirements. Resulting to be an interesting therapeutic approach, it is
defined as the use of the immune system and its products to prevent, treat
and control cancer. It may act stimulating the immune system of a cancerous
patient in order to eliminate or control the population of cancer cells and
consists, as already mentioned, in stimulating the IS in order to better fight,
and hopefully eradicate a cancer.
We will refer now to generic immunostimulations for example via cy-
tokines. The use of cytokine alone to boost the immune system represents
one of the most commonly used methods in immunotherapy. The stimu-
lation of an immune system in order to provide an effective treatment of
cancer diseases can be realized with the aid of vaccinations.
If the cancer is very aggressive, the immune system is unable to stop the
development of the neoplasm, despite the identification of cancer cells. In
this case cancer vaccine can be very useful, thus within its application we
still have to deal with the activation of the immune system. The vaccine
has now the character of a treatment, not that of prevention.
2.3 Mathematical Models in Cancer Research
The fight against cancer required many efforts in the last century and will
require greater efforts in the future. The idea is to gain understanding of
the process and to design better treatment strategies or improve existing
ones to eradicate the disease or at least to improve the patient’s quality
of life. To be successful it is to be hoped the fullest possible cooperation
among different scientists: primarily biologists, immunologists and medical
doctors, but also physicists and mathematicians who can provide valuable
support to research in this field.
The role of mathematics - modeling complex systems and yielding numer-
ical simulations - stays between phenomenological observation and physical
reality. Mathematical models can be good approximations of the system
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which is being modeled and can contribute to heighten the understanding
of reality.
Moreover, a model can be useful to decompose a very complex system
into more simple elements and to reproduce some particular behaviors of
these selected aspects. Different models of the same situation, with differ-
ent simplifying assumptions, can provide useful complementary insights and
levels of descriptions.
A good mathematical model can be useful to formulate ideas precisely
in a concise language and gives the possibility to use theorems, to interpret
data and to stimulate experiments. Besides, computational resources can aid
to confirm or reject hypothesis, to reveal contradictions and incompleteness
and to suggest the existence of new phenomena.
As a consequence, using models and simulations can reduce the cost of
experiments, the investigation times and predict dynamics under untested
or untestable hypothesis. Nevertheless, the interplay of different scientists
in the cancer research field can also promote the development of new math-
ematics.
There is a sequence of increasingly sophisticated models in the literature
that concern immune response to tumor (among whose models with reaction-
diffusion formulation; regarding the growing tumor as a deterministic dy-
namical system; using kinetic-cellular theory, ...)
Referring to what has been said in the previous section, tumor-immune
can be modeled in the framework of populations dynamics models following
a predator-prey paradigm to describe the response of effector cells (ECs)
to the growth of tumor cells (TCs), eventually adding a term describing
immunotherapy. We follow this approach describing the process in terms
of ODE or DDE. Many papers in literature present competition models of
tumor growth and immune system interaction using both ODE and DDE
and analyzing the effect of a delay term ([10], [11], [14],[17], [18], [12], [16],
[21], [19], [23],[15]).
2.3.1 Some relevant models
We have made a critical study of existing literature concerning tumor-
immune system interaction. For brevity we can not discuss many of the
models studied, but we report in this section a description of the main fea-
tures of models that we considered as the most important, both for their
historical importance, and for the subsequent extensions developed in this
work.
As a first example we report a brief summary of features and purposes
of the model presented in [14] by Kuznetsov et al. which can be considered
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as a point of departure for many models on the topic.
In this paper the authors analyze a model of cell mediated response
to a growing cancer cell population, taking into account the possibility of
infiltration of the tumor by effector cells and the possibility of effector cell
inactivation.
The interaction between effector cells (EC) and tumor cells (TC) is de-
scribed by the kinetic scheme:
E + T ∗
↗
E + T ­ C
↘
E∗ + T
where E, T, C, E*, T* are the local concentrations of effector cells, tu-
mor cells, effector cell-tumor cell conjugates, inactivated effector cells, and
”lethally hit” TC cells, respectively.
Mathematically the considered model for the interaction between EC
and a growing immunogenic tumor in vivo is:
dE
dt
= s+ F (C, T )− d1E − k1ET + (k−1 + k2)C,
dT
dt
= aT (1− bT )− k1ET + (k−1 + k3)C,
dC
dt
= k1ET − (k−1 + k2 + k3)C,
dE∗
dt
= k3C − d2E∗,
dT ∗
dt
= k2C − d3T ∗,
(2.1)
The parameters k1, k−1, k2 and k3 are non-negative kinetic constants:
k−1 and k1 describe the rates of binding of EC to TC and detachment of EC
from TC without damaging cells; k2 is the rate at which EC-TC interactions
irreversibly program TC for lysis; and k3 is the rate at which EC-TC inter-
actions inactivate EC. The parameter s is the ”normal” (non-enhanced by
TC presence) rate of flow of mature EC into the region of TC localization;
d1, d2 and d3 are positive constants representing the rates of elimination of
E, E* and T* cells, respectively, resulting from their destruction or migra-
tion from the TC localization area; a is a coefficient of the maximal growth
of tumor and b is the environment capacity.
The function F (C, T ) characterizes the rate at which cytotoxic effector
cells accumulate in the region of TC localization due to the presence of the
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tumor and the form suggested for this function is of Michaelis-Menten type:
F (C, T ) =
fC
g + T
, f, g > 0.
In fact this functional form is consistent with a model in which one assumes
that the accumulation of effector cells is due to signals, such as released
cytokines, generated by effector cells in conjugates. Further note that the
rate of stimulated accumulation has some maximum value as T gets large.
This is consistent with limitations in the rate of transport of effector cells
to the tumor. The rate limitation could occur in the circulation, in the rate
of exit from the circulation, or in the rate of movement through the tissue
to the tumor. A function of this form also adequately describes the rate of
lymphocyte accumulation into allogeneic tumor spheroids in mice when the
concentration of infiltrating macrophages is constant or changes slowly.
This model is slightly simplified thanks to biological meaningful approx-
imations. Firstly is observed that variables T* and E* have no effect on
each other or on the other variables in the system. Then only the first three
equations, dictating the behavior of system, are analyzed.
Then is argued that formation and dissociation of cellular conjugates C
occurs on a time scale of several tens of minutes to a few hours, whereas
the multiplication as well as influx of effector cells into the spleen occurs
on a much slower time scale, probably tens of hours. This motivates the
application of a quasi-steady-state approximation to third equation yielding
the relation:
C ≈ KET,
whereK = k1k2+k3+k−1 . Finally, since experimental observations indicate that
EC-TC conjugates usually comprise a small portion of the total number of
effector or tumor cells, the approximation Ttot ≈ T is made.
The simplified system results:
dE
dt
= s+
pET
g + T
− d1E −mET,
dT
dt
= aT (1− bT )− nET.
(2.2)
where p = fK, m = Kk3, n = Kk2.
System is then non-dimensionalized by choosing an order-of-magnitude
concentration scale for the E and T cell populations, E0 and T0, respectively.
Time too is scaled relative to the rate of tumor cell deactivation: t˜ = nT0t.
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Non-dimensional model can be written as:
dx
dt˜
= αx(1− βx)− xy,
dy
dt˜
= σ +
ρxy
η + x
− µxy − δy;
(2.3)
where:
x = TT0 , y =
E
E0
, σ =
s
nE0T0
, ρ =
p
nT0
,
η =
g
T0
, µ =
m
n
, δ =
d1
nT0
, α =
a
nT0
, β = bT0.
(2.4)
Then steady state are considered examining the nullclines. A disease free
steady state (0, σδ ) always exists and its stability depends upon the relative
values of the parameters for the system. In addition, depending upon the
intersections of nullclines there may be from zero to three additional steady
states for the system.
The stability of steady states and the qualitative behavior of the system
is studied using techniques from bifurcation theory with the aim to analyze
mechanisms of tumor dormancy and sneaking through. Tumor dormancy is
a term used to describe a state in which potentially lethal tumor cells persist
for a prolonged period of time with small or no increase in the tumor cell
population. Sneaking through refers to a phenomenon in which low doses
of cancer cells can escape immune defenses and grow into a large tumor,
whereas larger doses of tumor cells are eliminated. Parameter regimes are
delineated in which these behaviors can be expected: tumor dormancy, es-
cape from immunoregulation and sneaking through. It is also proved, using
the Dulac-Bendixson criterion that there are no closed orbits and that no
periodic dynamics arise for the system for positive values of x and y. More-
over, no Hopf bifurcations giving rise to limit cycles occur.
The model is tested choosing parameters obtained by fitting the results of
experiments on the dynamics of growth of a BCL 1 lymphoma in the spleen
of chimeric mice.
The analysis made shows that a non-zero rate of effector cell inactivation
is required to obtain sneaking through. Bifurcations analysis carried out
for realistic values of the parameters shows that sneaking through, tumor
dormancy and the immunostimulation of tumor growth, may all be related
and explained by the same model in different parameter regimes.
Although limit cyles do not arise in this model, simulations show that
transients in the vicinity of tumor dormancy steady state exhibit decaying
oscillations; it is also interesting that the predicted time scale of such oscil-
lations, 3 or 4 months, is in rough agreement with the time for recurrent
clinical manifestations of certain human leukemias.
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Furthermore, this model may be applicable to other biological processes
such as the infection of T cells by HIV.
Starting from the model (2.1) of Kuznetsov et al. presented above ([14]),
Galach in [12] have presented another model adding a delay term. One of
the main features of this delayed model is that it exhibits also oscillatory
dynamics.
Firstly a simplified model is studied, utilizing biological approxima-
tions made by Kuznetsov and taking F of Lotka-Volterra form instead of
Michaelis-Menten form as in the model above; that is F becomes bilinear
and has the form F (C, T ) = F (E, T ) = θET .
The simplified, non-dimensional model is:
dx
dt
= αx(1− βx)− xy,
dy
dt
= σ + ωxy − δy
(2.5)
where x denotes the dimensionless density of the population of TCs and y
stands for the dimensionless density of ECs. Parameters α, β, σ, δ are
defined as in (2.4) and ω =
θ −m
n
.
Analyzing stability of steady states and features of this system and com-
paring results with the model of Kuznetsov, it is showed that the dynamics
of simplified model are simpler than the dynamics of the original one.
However, solutions to both models are usually similar, it is noticed that with
simplified model it is possible to describe the dormant tumor and the tumor
escape under immunoregulation, but not the sneaking-through mechanism.
It is also proved that there is no nonnegative periodic solution of the system,
ruling out oscillatory dynamics.
Afterwards a delay term is added to the simplified model representing
the time needed by immune system to develop a suitable response after the
recognition of cancer cells.
The considered delayed model is then:
dx
dt
= αx(1− βx)− xy,
dy
dt
= σ + ωx(t− τ)y(t− τ)− δy,
(2.6)
where τ is a constant time delay.
Studying analitically this system is observed that steady states are the
same as in the simplified model, but the stability or instability of these states
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are more difficult to prove and equilibrium points can change their stability
with respect to the case without delay.
Moreover, the behavior of solutions is also more complex than that
for simplified model. In fact tumor dormancy behavior is observed with
small values of delay and we note the appearence of oscillations in solutions
and a state of returning tumor when higher values of delay are considered.
Sneaking-through mechanism is not observed with this model whereas tumor
escape under immunoregulation can be described depending on the param-
eter values.
Finally, as a last example, we will report a family of models proposed
in [10] by d’Onofrio. We are very interested in this family because we will
generalize this model in the next chapter and then we will add to generalized
system a delay term both of discrete and distributed type (chapters 4 and
5).
This family of models is constructed drawing on precedent models. More-
over, the killing of lymphocytes is seen as a function of tumor size and the
influx of lymphocytes too is taken as a function of entity of disease. Many
terms are then generalized: the influx function, the interaction term, the
term representing saturation in the predation, and the form of function de-
scribing tumor growth.
The system considered is:
x′ = x(αf(x)− φ(x)y) (2.7)
y′ = β(x)y − µ(x)y + σq(x) + θ(t)
where:
• x and y are respectively dimensionless quantities of tumoral and im-
mune cells;
• 0 < f(0) ≤ +∞, f ′(x) ≤ 0; f(x) summarizes different forms of growth
rate of the tumor;
• σq(x) is such that q(0) = 1; this term represents the influx of immune
cells in tumor situ, whose intensity may depend on the size of the
tumor. More precisely it may be non increasing, or initally increasing
and than decreasing; that is small tumors may stimolate the influx of
immune cells, while tumors in advanced state have the opposite effect.
• β(x) ≥ 0, β(0) = 0 e β′(x) ≥ 0; β(x) indicates the stimulating effect of
tumor on immune cells proliferation;
• µ(x) > 0 and µ′(x) > 0; µ(x) stands for the loss factor of immune cells
due to the presence of the tumor.
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• φ(x) > 0, φ(0) = 1, φ′(x) > 0 and xφ(x) → l < ∞; xφ(x) is the
functional response of tumor cells.
• θ(t) represents an eventual therapy term.
Using techniques similar to those utilized in [10], in the next chapter we
will study a generalized model that includes this as particular case. Then we
refer to the general case for a detailed analysis of properties of the system,
and here we discuss only general aspects of [10].
We point out that in the paper [10] an analysis is performed in the ab-
sence of therapy term, proving that this system always has a disease free
equilirium whose stability depend on values of parameter. In fact consider-
ing different functions (in particular taking different conditions on f , µ− β
and φ), it is proved that the disease free equilirium can be either locally
asymptotically stable (LAS), globally asymptotically stable (GAS), or un-
stable.
Moreover, studying nullclines intersections, it is proved that varying the pa-
rameters the system can also have an immune free equilibrium and some
equilibria with non null disease. Stability analysis of equilibria is carried
out, both stating conditions to have local asymptotic stability, both proving
propositions on global behavior of the system.
Concerning the possibility of periodic solutions, it is showed that with
exponential growth of the tumor (f(x) = 1) and if q(x) ≡ 0 for x > xq,
system may admit limit cycles.
But under more general conditions: if the nullcline corresponding to the first
equation (yc(x) = α
f(x)
φ(x)) is non increasing, then it is showed that Dulac-
Bendixson theorem excludes the possibility of limit cycles.
The inclusion of a therapy term is also investigated. An analytical and
numerical study is done for constant, periodic and impulsive therapies. Re-
sults point out that generally eradication due to immunotherapy is possible
but depends on initial values. Conditions for LAS and GAS of disease free
equilibrium are stated both for the case of constant therapy, both for peri-
odic scheduling.
It is also showed that the behavior of the system does not depend on the
shape of the therapy term but only on the mean value of this. Numerical
simulations of immunotherapy are performed choosing parameter on the
basis of the model proposed by Kuznetsov et al. [14] and realistic estimates
there reported.
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Chapter 3
A New Nonlinear Model of
Tumor-Immune System
Interaction
Let us introduce a new model describing tumor-immune system interaction,
generalizing system depicted in [10] and reported in 2.3.1.
The idea behind this model is to look at tumoral and immune cells as
two populations competing with each other, modifying interaction terms
according to the specific biological context and adding terms such as the
influx of immune cells in tumor situ, whose intensity may depend on the
presence of the tumor.
Cancer cells are considered as preys of immune cells. At the same time,
they stimulate proliferation of immune cells but also their loss, due to com-
petition between the two populations.
Mathematically we will study the system:
x′ = x(f(x)− Φ(x, y)) (3.1)
y′ = β(x)y − µ(x)y + σq(x) + θ(t)
where functions satisfy the same constraints as for system (2.7) reported in
the previoud chapter.
With respect to (2.7) in this model we have generalized the interac-
tion term φ(x)y by introducing Φ(x, y) representing that the competition
between populations is no more necessarily linear in y. We assume:
Φ(0, y) > 0, Φ(x, 0) = 0, (3.2)
the strict positivity of Φ(0, y) > 0 is required to allow the possibility of
immune surveillance, that is the possibility that immune system eliminates
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tumors. Moreover, the interaction term is assumed decreasing in the tumor
variable x and increasing in the immune variable y:
∂
∂x
Φ(x, y) ≤ 0 (3.3)
∂
∂y
Φ(x, y) > 0. (3.4)
Finally we assume some limit conditions: the interaction term becomes zero
when the tumor growths unboundendly:
lim
x→+∞Φ(x, y) = 0, (3.5)
and
lim
y→+∞Φ(x, y) = L(x), with: f(x) < L(x) ≤ +∞. (3.6)
The biological meaning of constraint (3.6) is that for a large level of immune
system effectors, there would be decrease of the tumor.
An example of Φ(x, y) is :
Φ(x, y) =
Ay
1 +Bx+ Cy
(3.7)
It will be useful to define ψ(x) = µ(x)− β(x) which we assume positive,
or positive in [0, x1) ∪ (x2,+∞) with ψ(x1) = ψ(x2) = 0. Moreover, we
assume that ψ(x) has an absolute minimum in [0,+∞) and this function
will be used to classify the interaction between tumor and immune system:
- ψ(x) > 0 = highly aggressive tumor: the capacity of destroying immune
cells is even higher than the stimulation effect of immune system.
- Variable sign of ψ(x) = lowly aggressive tumor: the two effects can balance
each other out.
Finally the term θ(t) represents a possible immunotherapy that may be
constant or periodic. We will treat therapy in section 3.5.
3.1 Nullclines
Now we will study properties of nullclines of system without therapy.
We denote with yc(x) the nullcline obtained putting x′ = 0 in the case x 6= 0,
that is yc(x) is such that:
Φ(x, yc(x)) = f(x) ∀x 6= 0. (3.8)
We denote with yi(x) the nullcline obtained putting y′ = 0, that is
yi(x) =
σq(x)
µ(x)− β(x) .
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As far as the nullcline yc(x) thanks to the constraints (3.4) and (3.6), it
follows that for all x ≥ 0 the function yc(x) is monodrome. Applying implicit
functions theorem to (3.8) one has that:
y′c(x) =
f ′(x)− ∂xΦ(x, yC(x))
∂yΦ(x, yC(x))
(3.9)
may have variable sign.
In the particular case (3.7) it is:
yc(x) =
f(x)
(A− Cf(x)) (1 +Bx) (3.10)
which is decreasing: y′c(x) < 0.
3.1.1 Disease Free Equilibrium
Considering system without therapy (θ(t) = 0), we initially study the disease
free equilibrium:
DFE = (0, yi(0)) (3.11)
which exists for every choice of parameter values.
The linearized system at DFE is:
x′ = [f(0)− Φ(0, yi(0)))]x
y′ = [β′(0)yi(0)− µ′(0)yi(0) + σq′(0)]x− µ(0)y, (3.12)
and, since µ(0) > 0, the local stability condition at this point (eradication
condition) is:
Φ (0, yi(0)) > f(0), (3.13)
which, remembering the definition of yc(x), reads as follow:
yi(0) > yc(0). (3.14)
After defining the following sets:
P = {x ∈ R+|yi(x) > 0} (3.15)
Q =
{
(x, y) ∈ R2+|y ≥MAX (yc(x), 0)
}
(3.16)
let us study the Global stability of DFE:
Theorem 3.1.1. If for x ∈ P it holds that:
yi(x) > yc(x) (3.17)
then DFE is GAS in R2+.
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Proof. Let us start by assuming the following simple Liapunov-La Salle func-
tion:
L = x. (3.18)
Then, we note that if (3.17) holds, the set Q is positively invariant for our
system. In fact, the curve
(x, yc(x)) (3.19)
is the lower border of Q, and on it we have:
y′|(x,yc(x)) > 0. (3.20)
In fact, if ψ(x) > 0 then we can rewrite
y′|(x,yc(x)) = ψ(x) (yi(x)− yc(x)) > 0, (3.21)
if ψ(x) = 0 then
y′|(x,yc(x)) = σq(x) + θ > 0, (3.22)
and finally if ψ(x) < 0
y′|(x,yc(x)) = ψ(x) (yi(x)− yc(x)) > 0, (3.23)
since where ψ(x) < 0 it is yi(x) < 0. Moreover, as it is easy to see, Q is also
attractive.
Finally, since in Q it is
dL
dt
|our model = x′ ≤ 0, (3.24)
then applying the LaSalle’s theorem it follows that DFE is GAS.
3.1.2 Equilibria with non null disease
The system may show multiple biologically meaningful non-eradicative equi-
libria given by intersections between nullclines.
Practically this means that the disease can evolve in different ways, reaching
states corresponding to stable equilibrium points.
A stable equilibrium point EQ = (xe, ye) with a small value of xe will
correspond to tumor dormancy, that is to a small tumor controlled by im-
mune system; whereas a stable equilibrium point with a higher value xe
corresponds to a large tumor, or also, depending on the value of xe to tu-
mor escape under immunoregulation, probably leading to the death of host
organism before equilibrium is reached.
Unstable points, instead, are not biologically meaningful, because they
are not physically observable.
It is then important to state condition for local asymptotic stability of
equilibria. Obviously we are interested only on points with positive coordi-
nates.
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Theorem 3.1.2. Let be EQ = (xe, ye) with xe > 0, ye > 0. If
ψ(xe)− xe∂yΦ(xe, ye)y′c(xe) > 0 AND y′i(xe) > y′c(xe) (3.25)
then EQ is local asymptotically stable (LAS).
Proof. Note that to have ye > 0 it must be:
ψ(xe) > 0.
The characteristic equation of the linearized system at EQ is:
λ2+
(
ψ(xe)− xe∂yΦ(xe, ye)y′c(xe)
)
λ+xe∂yΦ(xe, ye)ψ(xe)
(
y′i(xe)− y′c(xe)
)
= 0,
so applying Descartes’s rule of sign it is easy to see that if
ψ(xe)− xe∂yΦ(xe, ye)y′c(xe) > 0 AND y′i(xe) > y′c(xe) (3.26)
then both roots of characteristic equation have negative real parts, and the
equilibrium is LAS.
3.2 Limit cycles
This system can exhibit limit cycles. More precisely:
Theorem 3.2.1. Let DFE be unstable, and EQ = (xe, ye) be the unique
disease equilibrium point. Let it be yi(x) bounded in [0, x¯], and let it be
ψ(xe)− xe∂yΦ(xe, ye)y′c(xe) < 0 AND y′i(xe) > y′c(xe) (3.27)
then the system has at least a LAS limit cycle.
Proof. Condition (3.27) both implies the instability of EQ and it rules out
the possibility of homoclinic orbits. Moreover, the boundedness of yi(x)
implies that the set:
BB = [0, x¯]× [0,Maxx∈[0,x¯]yi(x)]
is positively invariant for our system. These two facts, thanks to the Bendixon-
Poincare` thricothomy imply the existence of at least a LAS limit cycle.
Theorem 3.2.2. Let DFE be unstable, and EQ = (xe, ye) be the unique
disease equilibrium point such that (3.27) holds. Moreover, let it be yi(x)
unbounded and increasing in [0, xas], with:
x̂ < xas < x¯
where
yc (x̂) = yDFE .
Then the system has at least a LAS limit cycle.
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Proof. In this case, it is easy to verify that the set
BB1 = [0, x̂]× [yDFE , yi (x̂)]
is positively invariant. Thus, since (3.27) holds, it easily follows the existence
of at least a LAS limit cycle.
3.3 Unique non-DFE equilibrium
Theorem 3.3.1. If there is a unique and LAS equilibrium point EQ, and
y′c(x) < 0 AND ψ(x) > 0
then EQ is GAS.
Proof. The positiveness of ψ(x) implies the boundedness of yi(x) implying,
in turn, that the set:
BB = [0, x¯]× [0,Maxx∈[0,x¯]yi(x)]
is positively invariant for our system. Moreover, since:
Div
(
x′
x
,
y′
x
)
= f ′(x)− ∂xΦ− ψ(x)
x
= y′c(x)−
ψ(x)
x
< 0, (3.28)
the GAS of EQ follows from the Bendixon-Poincare thrichothomy.
3.4 Examples
Example 1. As a first example we introduce a system which will be largely
utilized in the rest of this work to obtain numerical results.
We observe that taking parameters of the form:
f(x) = α (1− β˜x), Φ(x, y) = y, β(x) = ρx
η + x
,
σq(x) = σ, µ(x) = µ˜x+ δ,
(3.29)
we obtain as a particular case the adimensional model of Kuznetsov et al.
reported in (2.3). Then the estimate of parameters is made referring to
paper of Kuznetsov et al. [14] where values are fitted from real data obtained
with experiments on chimeric mice.
We have:
f(x) = 1.636 (1− 0.002x), Φ(x, y) = y,
β(x) =
1.131x
20.19 + x
, σq(x) = 0.1181, µ(x) = 0.00311x+ 0.3743,
(3.30)
Since these values are calculated after adimensionalazing the system, we have
treal = 9.9 tadim days.
And, as regards number of cells: (Xreal, Yreal) = 106(x, y)cells.
This system has 4 equilibrium points:
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• The disease free equilibrium: DFE = (0, 0.316) which is unstable;
• A microscopic LAS equilibrium point: Emicro = (8.1897, 1.6092);
• A saddle point: Eu = (267.798, 0.7598);
• A macroscopic LAS equilibrium point: Emacro = (447.1342, 0.173).
Example 2. A second model, that, as we will see, has different dynamical
behaviors with respect to the system presented in previous example, can be
obtained taking Φ(x, y) as in (3.7) and sligthly modifying the expression of
f(x): In particular we will take:
Φ(x, y) =
y
1 + 0.002x+ 0.25y
, f(x) = 1.636 (1− 0.00476x). (3.31)
All the other parameters remain as above. This model too will be largely
studied in the rest of this work.
This system has only two equilibrium points, both unstables:
• The disease free equilibrium: DFE = (0, 0.316);
• The point Ec = (9.6446, 3.0535).
The system with parameter taken as in [14] cannot exhibit limit cycles,
whereas cycles are possible in the system with parameters taken as in (3.31),
in fact all the hypothesis of above theorems hold for the equilibrium point Ec.
3.5 Therapy
In this section we add the therapy term θ(t) in the model studied in previous
sections.
We will consider two different types of therapies:
- Constant therapy: θ(t) = θm
- Periodic therapy: θ(t) = θm +Ω(t), θ(t+ T ) = θ(t)
Firstly we will make a qualitative analysis of constant case proceeding
as in [10] and then we will see some numerical results in the case of periodic
therapy.
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3.5.1 Constant therapy
In this case system becomes:
x′ = x(f(x)− Φ(x, y)) (3.32)
y′ = β(x)y − µ(x)y + σq(x) + θm
and substantially therapy has the effect of moving the stable equilibrium
point decreasing the value of xe.
To studying stability of new equilibrium we can carry out the same analysis
done in the case without therapy, but the nullcline yi(x) becomes:
yi(x; θ) =
σq(x) + θm
µ(x)− β(x) . (3.33)
In particular the LAS condition of disease free equilibrium is:
yi(0; θ) > yc(0); (3.34)
this condition is not global because of the presence of other equilibria; so
it does not correspond to tumor eradication, but depends on initial values
that are practically difficult to measure with sufficient precision.
If µ(x)−β(x) > 0, we have that yi(x; θ) > yi(x), then roughly speaking,
the stable equilibrium size of the cancer becomes smaller and the unstable
equilibria greater, so that the basin of attraction of the unbounded solution
is reduced.
In Figure 3.1 we see how constant therapy can also induce disease free
equilibrium to be GAS. In this case we have taken parameters as in (2.4)
and θm = 0.7 which can be considered a very strong therapy (probably
unrealistic) comparing for example this value with the constant influx of
lymphocytes that is σq(x) = 0.1181.
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Figure 3.1: Phase portrait in (x,y)-plane for system with parameters as in
(2.4) and constant therapy θm = 0.7. In this case DFE is GAS.
3.5.2 Periodic therapy
In the case of periodic therapy we can take into account two different ex-
pressions of θ(t):
- An expression more unrealistic, but mathematically simpler, which often
is utilized to describe forcing term to nonlinear systems:
θ(t) = θA(1 + cos(
2pi
T
t)), (3.35)
where θA represents the maximal quantity of drug present in the or-
ganism and T is the time lag between an administration and the next.
- A more realistic expression representing a boli-based therapy with admin-
istration time T :
θ(t) = θAexp(−ψMod(t, T )), (3.36)
where, as above, θA is the maximal quantity of drug, and ψ is a mea-
sure of clearance time of drug from the host organism: (ln 2/ψ) is the
half life of delivered drug.
To have an idea of the entity of the therapy we will write the mean
value:
M = θA
e−Tψ
(−1 + eTψ)
Tψ
. (3.37)
A quite realistic example, with T = 1 (roughly 10 days), θA = 0.1181,
and different values of ψ can be seen in Figure 3.2.
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Figure 3.2: Pattern of boli-based therapy administration with T = 1, θA =
0.1181 and different clearance times: very slow clearance ψ = 0.025, mean
value M = 0.1166 (on the left); average time of clearance ψ = 0.1, mean
value M = 0.1124 (on the right); fast clearance ψ = 0.9, mean value M =
0.0779 (down). In abscissa is reported time and in ordinate is reported
therapy value: θ(t).
In numerical simulations reported below, values of T are taken either of
the order of the period of limit cycle of the system without therapy (if it
exists), or in a more relistic interval: [0.1, 3] corresponding in dimensional
terms to: [1 day, 1 month].
We will make simulations only with boli-based form of periodic therapy
for its greater biological reliability.
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3.5.3 Numerical results
We show some results obtained adding different periodic therapies to the
system with limit cycle presented in the example 2 of the previous section:
x′ = x
(
1.636 (1− 0.00476x)− y
1 + 0.02x+ 0.25y
)
y′ =
1.131x
20.19 + x
y − (0.00311x+ 0.3743)y + 0.1181 + θ(t).
(3.38)
For θ = 0 the system exhibits a limit cycle of period P = 18, that is roughly
180 days (figure 3.3).
We will see how the qualitatively behavior of solutions varies considering
different periodic therapies.
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Figure 3.3: Solution x(t) (tumor cells) of system (3.38) without therapy.
Let us introduce a therapy of the form:
θ(t) = 0.1181 exp(−ψMod(t, T )), (3.39)
with θA = 0.1181 and consider different values of T and of ψ.
We remark here that, as we see also in Figure 3.2, a small value of ψ
indicates that the clearance is slower, so in the organism is ever present a
high quantity of drug, quite constant between an administration and the
next. Here we take as minimal value ψ = 0.025 corresponding to an half life
of the drug in the organism of approximately 9 months.
If, instead, the value of ψ is higher (the maximum that we take is ψ = 0.9
corresponding in dimensional terms to an half life of 11 days), so the clear-
ance is faster and the quantity of drug in the organism falls down between
an administration and the next.
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Obviously to decide how a therapy is enduring it is important not only
the clearance time (that is, in our case, ψ) and the value of θA, but also the
administration time T . In fact if the doses of drug are delivered very often
(that is T= time between an admistration and the next, is small), then the
organism will retain a high quantity of drug even if the cleareance is fast
(high value of ψ).
In Figure 3.4 administration times T are considered in a realistic range
(from 1 day to 1 month: T ∈ (0.1, 3), whereas in Figure 3.5 T is of the
order of P (in dimensional terms T is roughly from 5 to 8 months) which is
an unrealistic value for administration times, but, as we will see, interesting
mathematical phenomena occur for this values, such as resonance effects.
Values of ψ in both cases are taken as in the Figure 3.2, that is ψ = 0.025,
ψ = 0.1, ψ = 0.9.
In simulations below, the integration is made for a very large interval of
time (corresponding to roughly 15 years). Actually, a so lenghty treatment
is not biologically meaningful, but here we are mainly interested to show the
asymptotic behavior of solutions.
Now we report some numerical simulations of solution x(t) of system
(3.38) with a boli-based therapy.
In Figure 3.4 we notice that taking realistic adminstration times, we
obtain almost always the convergence to the new equilibrium point (which
becomes LAS in the majority of cases considered in this Figure); however,
also when a limit cycle persits, the size of oscillations decreases notably, re-
maining in an interval in which the tumor, although with periodic dynamics,
may be considered small.
In this case, in which the period of therapy and period of limit cycle are
very different, there are not resonance effects that instead are present when
T is of the order of P as we can see in figures 3.5 and 3.6.
It also important to remark that in this simulations eradication of tumor
is never achieved, not even with stronger therapies. Therapy has the only
effect to keep the tumor size in a controlled, microscopic state.
We can also observe that, since system without therapy has not LAS
equilibrium point, when treatment is interrupted, tumor restarts to grow
and the limit cycle will arise again.
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Figure 3.4: Solutions x(t) of system (3.38) with θA = 0.1181 and different
value of T and ψ: (a) ψ = 0.025, T=0.1; M=0.1180; (b) ψ = 0.1, T=1;
M=0.1124, (c) ψ = 0.9, T=0.1; M=0.1129; (d) ψ = 0.9, T=3; M=0.0408.
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Figure 3.5: Solution x(t) of system 3.38 with θA = 0.1181. (a) ψ = 0.1,
T=15; (b) ψ = 0.9, T=15; (c) ψ = 0.025, T=18; (d) ψ = 0.1, T=18; (e)
ψ = 0.1, T=20; (f) ψ = 0.9, T=20;
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Figure 3.6: Zoom of Figure 3.5 to highlight changes in period and amplitude
of limit cycles oscillations. Time value in abscissa are taken in the interval
(600,800); values of ordinate axis range in (0,90). In all graphs θA = 0.1181.
(a) ψ = 0.1, T=15; (b) ψ = 0.9, T=15; (c) ψ = 0.025, T=18; (d) ψ = 0.1,
T=18; (e) ψ = 0.1, T=20; (f) ψ = 0.9, T=20;
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In Figures 3.5 and 3.6 we observe that in all cases an oscillatory dynamics
persists.
On the other hand, we can make distinctions between different cases:
- for slower clearance times (ψ = 0.025) and smaller delivery times we
see that the size of oscillations decreases in time and presumably the system
will converge to the equilibrium point;
- for therapies with faster clearance times (ψ = 0.1 e ψ = 0.9), instead,
we continue to see a periodic or pseudoperiodic behavior, but, with respect
to oscillations in the system without therapy, we can notice a new effect
of modulation or resonances caused by the overlap of the two periodic pro-
cesses (the system and the therapy).
Moreover, in the Figure 3.6 we have collected some graphs where the
same solutions of the Figure 3.5 are depicted, but selecting and zooming an
interval of times ([600,800] rather than [0,800]) to highlight differencies not
only in qualitative behavior, but also in size and period of oscillations.
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Chapter 4
Mathematical analysis of the
effect of delays between
tumor growth and
stimulation of immune cells
proliferation
In this chapter we want to study what occurs to the system (3.1) adding
a delay in β(x), that is in the proliferation rate of immune system cells
accounting for the presence of tumor.
The effect of time delay is taken into account in order to achieve a bet-
ter compatibility with reality and to approximate missing dynamical com-
ponents such as, chemical signals, B-lymphocytes-mediated maturation and
activation of T-lymphocytes. In fact, immune system needs time to identify
the tumor and to adequatly react with the counterattack of T lymphocytes,
and this time lag - which is an organism characteristic time - can be used
as control parameter of immune response.
Periodicity in tumor growth and in oncological diseases are sometimes
observed in reality. Another reason to study delay models of tumor-immune
system interaction is that these models can produce limit cycles that non-
delayed models do not exhibit. In fact as we have seen in section 1.6 in the
example of delayed logistic equation; introducing a delay term in the model
can produce periodic dynamics. Then with delayed models we can explain
observed periodicities.
In this work we have studied the model presented in previous chapter
adding both a fixed lag delay, and distributed delays with some special
integration kernels.
We have carried out an analytical study addressed particularly to changes
in stability of equilibrium points via Hopf bifurcations and to possibility
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of periodic solutions. We have also performed many numerical simulations
taking values of parameters within the range of biological significance.
In this chapter we treat the case of discrete delay; whereas in the chapter
5 distributed delays are considered.
4.1 Fixed lag delay
Following some papers about specific models of tumor-immune system inter-
action ([12], [18], [21], [23]), in this chapter we add a fixed lag delay in term
representing the proliferation rate of immune system cells accounting for the
presence of tumor. Conversely to the approach followed by many authors in
literature, we add the delay term only in the proliferative function β(x) and
not in the immune system variable y in analogy to the derivation of delayed
logistic function where the delay term is introduced only in the growth rate
function F (x) = (1− x/K) and not in the term x(t) (see section 1.6).
We will analyze delayed system and in particular we will point out the
possibility of changes in stability properties of equilibrium points via Hopf
bifurcations. With the aim to study destabilizing properties of delay we will
use as bifurcation parameter the delay τ .
The system with the new term β(x(t− τ)) becomes{
x′ = x(f(x)− Φ(x, y))
y′ = β(xτ )y − µ(x)y + σq(x). (4.1)
where xτ (t) = x(t− τ), τ ∈ R+.
Equlibrium points are the same with respect to the system without delay.
With regard to disease free equilibrium we have the next simple result:
Proposition 4.1.1. The equilibrium point disease free DFE = (0, yi(0))
does not change its stability for any τ > 0.
Proof. Referring to the analysis of stability of DFE done in 3.1.1 in the
nondelayed case, we only have to note that the delay does not affect the
linearized equation for x:
x′ = x(f(0)− Φ(0, yDFE)) (4.2)
then LAS condition is the same as in nondelayed case, that is:
Φ(0, yi(0)) > f(0) (4.3)
and does not depend on the delay.
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Now we study the equilibria with non null disease: E = (xe, ye). To
analyze the stability of these points, first of all we write the linearized system:
d
dt
u(t) = Hu(t) +Nv(t)
d
dt
v(t) = Qu(t− τ) + Su(t) +Rv(t)
(4.4)
where:
H = xe
(
f ′(xe)− ∂xΦ(xe, ye)
)
(4.5)
N = −xe∂yΦ(xe, ye) < 0 (4.6)
Q = yeβ′(xe) ≥ 0 (4.7)
S = −yeµ′(xe) + σq′(xe) (4.8)
R = β(xe)− µ(xe) = −ψ(xe) < 0. (4.9)
In this chapter we will make large use of the notations H,N,Q,R, S, so
we rewrite the LAS conditions (3.25) as:
H +R < 0; (4.10)
HR > N(Q+ S). (4.11)
With introduced notations, the characteristic equation of the system is:
λ2 − (H +R)λ+ (HR−NS)−NQe−λτ = 0. (4.12)
About which we want to find purely imaginary roots, that is, setting
λ = iω, ω ∈ R solutions of the equation:
−ω2 − i(H +R)ω + (HR−NS)−NQ(cosωτ − isenωτ) = 0. (4.13)
Separating real and imaginary part we have:
−ω2 + (HR−NS)−NQcosωτ = 0
−(H +R)ω +NQsenωτ = 0
(4.14)
that is: 
cos(ωτ) =
(HR−NS)− ω2
NQ
sen(ωτ) =
(H +R)ω
NQ
(4.15)
From which we obtain the biquadratic equation in ω:
ω4 + (H2 +R2 + 2NS)ω2 + (HR−NS)2 − (NQ)2 = 0 (4.16)
which we rewrite as follows:
ω4+(H2+R2+2NS)ω2+(HR−NS−NQ)(HR−NS+NQ) = 0 (4.17)
We will continue subdividing the analysis in all possible cases, treated
according to their biologic relevance.
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4.1.1 EQ is LAS and q′(xe) ≤ 0
This case is biologically very important because it represents a physically
observable equilibrium with constant or decreasing effector influx.
In other terms, the size of tumor can be macroscopic or microscopic, but
not so small to be in a range with increasing effector influx.
In this case NS > 0, and:
HR−NS −NQ > 0. (4.18)
With the delay τ the equilibrium point EQ can remain LAS for any τ > 0,
or it may lose stability if the delay overcomes a critical value τ0,1.
More precisely we have:
Proposition 4.1.2. Let EQ = (xe, ye) be an equilibrium point with non
null disease of system (4.1), which is LAS for τ = 0 and let q′(xe) ≤ 0.
If in EQ we have (HR − NS + NQ) ≥ 0, then EQ will be LAS for any
τ > 0.
If in EQ we have:
HR−NS +NQ < 0, (4.19)
Then there is a critical value τ0,1 and EQ is stable if τ < τ0,1, and it is
unstable if τ > τ0,1. In τ = τ0,1 there is a Hopf bifurcation.
Proof. To study the possibility of stability changes varying the delay τ , we
have to verify conditions for which it is possible to have Hopf bifurcations;
therefore we will study solutions of equation (4.17), that is, purely imaginary
roots λ = iω of characteristic equation.
Formally solutions of (4.17) are given by:
ω2± =
−(H2 +R2 + 2NS)±√∆
2
(4.20)
where ∆ = (H2 −R2)2 + 4NS(H +R)2 + 4N2Q2.
Since NS > 0, we have a positive root ω2+ if and only if
(HR−NS +NQ)(HR−NS −NQ) < 0, (4.21)
that is (4.19), remembering that EQ is LAS and therefore (HR − NS −
NQ) > 0.
To complete the proof we have to study the sign of the derivative of
Reλ(τ) at the points where λ(τ) is purely imaginary. For the sake of sem-
plicity we study the sign of inverse:(
dλ
dτ
)−1
=
2λ−H −R+ τNQe−λτ
−λNQe−λτ =
−2λeλτ + (H +R)eλτ − τNQ
λNQ
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Setting λ = iω+ and taking real part we have:
Re
(
dλ
dτ
)−1
|λ=iω0=
−2cosωτ
NQ
+
(H +R)senωτ
ωNQ
=
−2(HR−NS) + 2ω2+ + (H +R)2
(NQ)2
and this derivative is positive in ω2+, so there is a Hopf bifurcation with loss
of stability in
τ0,1 =
θ1
ω+
(4.22)
where θ1 is such that 0 ≤ θ1 < 2pi and
cosθ1 =
(HR−NS)− ω2+
NQ
, senθ1 =
(H +R)ω+
NQ
. (4.23)
4.1.2 EQ is LAS and q′(xe) > 0 but S < 0
This case is mathematically equivalent to the previous one, nevertheless we
distinguished it because it is biologically deeply different. In fact it corre-
sponds to a microscopic equilibrium where the effector influx is increasing:
q′(xe) > 0, but it also is q′(xe) < yeµ′(xe).
All the observations made in the previous section are still valid, so we have
to verify the condition:
HR−NS +NQ < 0. (4.24)
If this inequality holds there will be a Hopf bifurcation with loss of
stability in τ = τ0,1 where τ0,1 is calculated with (4.22)-(4.23); else, if (4.24)
does not hold, the equilibrium point is stable for any τ > 0.
4.1.3 EQ is LAS but NS < 0
This case biologically represents a microscopic equilibrium with an extremely
small tumor size where the stimulation activity on the influx of effectors is
so high that q′(xe) > yeµ′(xe).
In this case there are many possible behaviors.
Arguing as in the previous sections we have that if HR − NS + NQ < 0,
then the biquadratic equation (4.17) has two real roots ±ω+ and there is
a Hopf bifurcation with loss of stability in τ = τ0,1 where τ0,1 is given by
(4.22)-(4.23).
Else, if HR−NS +NQ > 0 and following conditions hold:
2NS < −H2 −R2, (4.25)
(H2 −R2)2 + 4NS(H +R)2 + 4(NQ)2 > 0, (4.26)
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then the biquadratic equation (4.17) has four distinct real solutions:
±ω+, ±ω−, where ω+, ω− > 0 are the roots of:
ω2± =
−(H2 +R2 + 2NS)±√∆
2
(4.27)
and Re
(
dλ
dτ
)
|λ=iω± is positive in ω+ and negative in ω−.
So, defined:
τn,1 =
θ1
ω+
+
2npi
ω+
(4.28)
with 0 ≤ θ1 < 2pi and
cosθ1 =
(HR−NS)− ω2+
NQ
, senθ1 =
(H +R)ω+
NQ
. (4.29)
τn,2 =
θ2
ω−
+
2npi
ω−
(4.30)
with 0 ≤ θ2 < 2pi and
cosθ2 =
(HR−NS)− ω2−
NQ
, senθ2 =
(H +R)ω−
NQ
. (4.31)
for n = 0, 1, 2, ..., we have:
Proposition 4.1.3. Let EQ = (xe, ye) be an equilibrium point for the sys-
tem (4.1) with non null disease, which is LAS for τ = 0, and in which we
have q′(xe) > 0, S > 0.
If in EQ it holds:
HR−NS +NQ < 0, (4.32)
then a Hopf bifurcation occurs in τ = τ0,1 given by (4.22)-(4.23) and EQ in
LAS for τ < τ0,1, and unstable for τ > τ0,1.
If in EQ we have:
HR−NS +NQ > 0, (4.33)
2NS +H2 +R2 < 0, (4.34)
(H2 −R2)2 + 4NS(H +R)2 + 4(NQ)2 > 0, (4.35)
Then EQ is LAS for τ < τ0,1, and in τ = τ0,1 a Hopf bifurcation occurs with
loss of stability. Moreover, if τ0,2 < τ1,1 stability is recovered in τ = τ0,2 and
there are a finite number of stability switches, whereas if τ0,2 < τ1,1 stability
is lost definitively.
Finally, if (4.33) holds, but (4.34) or (4.35) are not satisfied, EQ will
remain stable for any τ > 0.
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4.1.4 EQ is unstable and there are no limit cycles
In this case in absence of delay the resulting equilibrium is not biologically
observable, thus one might speculate that the introduction of a delay might
stabilize it, although usually the effect of delays is unstabilizing. Our anal-
ysis shows that such stabilization does not hold.
In fact in this case two tipes of equilibrium points are summarized:
• EQ unstable; H +R < 0 and HR−NS −NQ < 0;
• EQ unstable; H +R > 0 and HR−NS −NQ < 0.
Both cases correspond to saddle points for the system without delay and
adding delay does not involve any qualitative change.
4.1.5 EQ is unstable, H +R > 0 but HR−NS −NQ > 0
In this case EQ in the system without delay is unstable, but we have occur-
rence of limit cycles if EQ is the only equilibrium with non null disease.
Adding the delay we observe that oscillatory dynamics may overstay;
but we will see that in this case, differently from the previous one, delay
can have a stabilizing effect, that is, under certain assumptions, increasing
the value of delay, that there may be stability switches from instability to
stability. More precisely we have:
Proposition 4.1.4. Let EQ be an unstable equilibrium point with non null
disease in which H+R > 0 and HR−NS−NQ > 0. If, moreover, following
conditions hold:
HR−NS +NQ > 0, (4.36)
2NS +H2 +R2 < 0, (4.37)
(H2 −R2)2 + 4NS(H +R)2 + 4(NQ)2 > 0; (4.38)
then there may be a finite number of stability switches from instability to
stability.
Proof. We first remember the biquadratic equation:
ω4+(H2+R2+2NS)ω2+(HR−NS−NQ)(HR−NS+NQ) = 0 (4.39)
and we observe that the condition (4.38) is equivalent to the positiveness of
the determinant, and therefore there are two distinct real roots:
ω2± =
−(H2 +R2 + 2NS)±√∆
2
(4.40)
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whereas conditions (4.37) and (4.38) imply that both the roots are positive.
Following theory of the section 1.5.1 and proceeding as in the Proposition
4.1.3 we can define:
τn,1 =
θ1
ω+
+
2npi
ω+
(4.41)
and
τn,2 =
θ2
ω−
+
2npi
ω−
(4.42)
where θ1, θ2 are such that 0 ≤ θ1 < 2pi, 0 ≤ θ2 < 2pi and
cosθ1 =
(HR−NS)− ω2+
NQ
, senθ1 =
(H +R)ω+
NQ
. (4.43)
cosθ2 =
(HR−NS)− ω2−
NQ
, senθ2 =
(H +R)ω−
NQ
. (4.44)
for n = 0, 1, 2, ....
The molteplicity of roots with Reλ > 0 increases and decreases of two units
when τ passes through τn,1 or τn,2 eventually leading to stability switches.
If hypothesis of previous proposition do not hold, the system continues
to have an oscillatory dynamics for any value of delay.
In the section 4.2.4 we will see, through numerical simulations, that delay
has however some effect on the limit cycle which changes slightly its shape.
In fact the state variable x (representing the size of tumor), assumes higher
values increasing the delay. Furthermore, will see that the period of cycle
also increases while τ is growing.
4.2 Numerical simulations
We will report in this section some numerical simulations with the aim to
give biologically meaningful examples of different cases analyzed previously.
To estimate system parameters, at the beginning we refer to paper of
Kuznetsov [14], that is we consider the system described in the example 1
of previous chapter:
x′ = x(1.636 (1− 0.002x)− y)
y′ =
1.131xτ
20.19 + xτ
y − (0.00311x+ 0.3743)y + 0.1181
(4.45)
We rembember here that this system has 4 equilibrium points:
• The disease free equilibrium: DFE = (0, 0.316) which is unstable;
• A microscopic LAS equilibrium point: Emicro = (8.1897, 1.6092);
66
CHAPTER 4. MATHEMATICAL ANALYSIS OF THE EFFECT OF
DELAYS BETWEEN TUMOR GROWTH AND STIMULATION OF
IMMUNE CELLS PROLIFERATION 4.2
• A saddle point: Eu = (267.798, 0.7598);
• A macroscopic LAS equilibrium point: Emacro = (447.1342, 0.173).
Moreover, we remember that treal = 9.9 tadim days.
Next we will refer to this relation to verify the biological reliability of values
of delays utilized in our numerical simulations and of critical values of τ for
which bifurcations occur.
Delay considered in our analysis can be due to many factors: above all
to the time lag needed by immune system to notice tumor presence and to
start to produce differentiated cells ables to compete with it; secondly to
proliferation time, that is division cell lenght, normally valued between 0.9
and 12 days [18], [19]; and finally to time lag that immune cells need to
reach tumor situ.
In literature typical delays are estimated between 1 and 20 days [18],
[21], but for critical values of delays in which Hopf bifurcations occur we
find times from 1 to roughly 50 days [23].
4.2.1 EQ is LAS and q′(xe) ≤ 0
We can see, as a first example, the behavior of two LAS equilibrium points
Emicro, Emacro of the system (4.45) with the add of a delay term.
In the section 4.1.1 we have proved that two behaviors are possibles: the
equilibrium point remains LAS for any value of delay, or a Hopf bifurcation
occurs with loss of stability.
With respect to two points considered, we have that in Emicro condition
(4.19) holds and the critical bifurcation value is τbif = 0.2692; whereas in
Emacro condition (4.19) does not hold and the point remains stable.
We show the bifurcation diagram at the point Emicro in Figure 4.1. We
see that for τ = τbif a Hopf bifurcation occurs and dynamics is cyclic until
around τ = 1.09 (value obtained numerically).
After this thereshold the point Emicro remains unstable, but limit cycles
break down and the system converge to Emacro that is LAS for every value
of delay.
To better see different dynamics, in Figure 4.2 we showed the behavior
of solutions of system (4.45) with different, increasing, values of delay taking
initial conditions close to Emicro.
We see that for small delays the equilibrium point is still LAS (4.2-a), but
when τ passes through τbif (figure 4.2-b), solutions start oscillate and the
size of cycles becomes larger and larger as τ increases.
Finally (figure 4.2-c) for greater values of delay solutions converge to Emacro.
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Figure 4.1: Bifurcation diagram of system (4.45) at the equilibrium point
Emicro plotted in logarithmic scale.
In Figure 4.3 we summarized in a phase portrait different asymptotical
dynamical behaviors of solution x(t) of the system (4.45), showing how the
point Emicro is LAS for values of delay less than τbif , and exhibits limit
cycles of increasing amplitude as delay increases. Finally, when τ > 1.09,
limit cycles break down and we have convergence to Emacro.
It is interesting to note that not only amplitudes of cycle, but also periods
increase as delay increases. To see this we have reported in Table 4.2.1 values
of period and amplitude of limit cycles for different increasing values of τ .
This increasing trend in periods and amplitudes can be observed also
in Figure 4.4 where we reported long-term time paths of solutions x(t) of
tumor variable for some values of those seen in Table 4.2.1.
Concerning what we said discussing about tipical and biological mean-
ingful values of delay, we see that the critical value found for this first model:
τbif = 0.2692
corresponds to 2.66 days, and so it lies in the range of acceptable values.
We can imagine that in an organism suffering from tumor, the effective delay
in proliferation of immune system can be either less or greater than τbif de-
pending on the individual. So, depending on the circumstances, tumor can
have or not an oscillatory behavior. Moreover, it is possible that this delay
varies in time for different reasons (age, environment, diseases,...) and that
consequenly system passes from an oscillatory dynamics to one convergent
to Emicro and viceversa, until variables do not lie in the attraction basin of
Emacro that is LAS independently on delay value.
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Figure 4.2: Solutions x(t) (cancer cells) on the left and immune cells y(t)
(on the right) of system (4.45) with initial conditions close to equilibrium
point Emicro. Values of delay are: (a) τ = 0.1; (b) τ = 0.6; (c) τ = 1.2.
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Figure 4.3: Phase portrait in (x,y)-plane of solutions of system (4.45) for
different values of delay.
Delay (τ) Cycle Period Amplitude
0.3 11.6 21.8
0.35 12.5 36.4
0.4 13.5 50.3
0.45 14.5 64.3
0.5 15.3 78.4
0.55 16.3 92.5
0.6 17.2 106.9
0.65 18.1 121.3
0.7 19 135.9
0.75 20 150.6
0.8 21.2 165.6
0.85 22.3 180.8
0.9 23.7 196.4
0.95 25.1 212.3
1 27 229.1
1.05 29.9 247.3
Table 4.1: We reported in this table periods and amplitudes of cycles of
variable x(t) dependent on delay. Data are referred to system (4.45) in the
range of delay values when limit cycle is present. We note how both periods
and amplitudes increase as τ increases.
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Figure 4.4: Solutions x(t) (cancer cells) of the system (4.45) with initial
conditions close to equilibrium point Emicro. In abscissa was taken an inter-
val of time of lenght 100 units. We can observe differences in periods and
amplitudes of cycles, and compare these graphs with data in Table 4.2.1.
Values of delay are: (a) τ = 0.3; (b) τ = 0.5; (c) τ = 0.8; (d) τ = 1.
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4.2.2 EQ is LAS and q′(xe) > 0 but S < 0
In this section we study an equilibrium point with non null disease in which
the conditions:
1 - EQ = (xe, ye) LAS;
2 - q′(xe) > 0;
3 - S = −yeµ′(xe) + σq′(xe) < 0
hold. To have such a point we slightly modified system (4.45), setting :
Φ(x, y) =
y
1 + 0.01x+ 0.5y
, (4.46)
(4.47)
σq(x) =Min(0.01181 + 0.009x , 0.1181), (4.48)
and taking other parameters as in (4.45).
This system when τ = 0 has 4 equilibrium points:
- The disease free equilibrium DFE = (0, 0.3155) which is unstable;
- A LAS equilibrium point E1 = (10.925, 8.881), corresponding to a micro-
scopic tumor;
- A saddle point E2 = (219, 719, 5.415);
- Another LAS equilibrium point E3 = (492.662, 0.144) corresponding to a
macroscopic tumor much bigger than E1.
Moreover, in E1 we have S < 0.
In this case again a Hopf bifurcation occurs in τh = 0.2015 with loss of
stability for E1. In Figure 4.5 different numerical simulations are showed
with increasing values of τ and with initial conditions close to E1.
The qualitatively behavior is analogous to that discussed above for Fig-
ure 4.2 in section 4.2.1: again we can see how for delay less than bifurcation
value the equilibrium point E1 is LAS. Then, increasing τ above τh, we have
range where dynamics is cyclic; and finally, when the delay exceeds a critical
value τc, greater than τh, the cycle breaks down and solutions converge to
macroscopic equilibrium point E3.
Here we have reported only Figure 4.5 where the three possible patterns of
solutions are showed.
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Figure 4.5: Solutions of system described in section 4.2.2 with initial condi-
tions close to equilibrium point E1. x(t) (cancer cells) on the letf and y(t)
(immune cells) on the right. Values of delay are varied: (a) τ = 0.1; (b)
τ = 0.4; (c) τ = 0.8
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4.2.3 EQ is LAS but NS < 0
In this section we show the behavior of the system which has all parameters
equals to model (4.45) except for:
σq(x) =Min(0.01181 + 0.01181x , 0.1181).
Such a system, in fact, has an equilibrium point with non null disease E =
(8.3724, 1.6086) which is LAS when τ = 0 and in which NS < 0.
The others equilibrium points of the system are:
- The disease free equilibrium DFE = (0, 0.3155), unstable;
- An unstable point U = (267.79, 0.7597);
- A macroscopic LAS equilibrium ES = (447.134, 0.173).
E is LAS when τ = 0, but the stability is lost via Hopf bifurcation when
τ > τbif = 0.2564.
Some numerical simulatons showing the behavior of solutions x(t) and y(t)
of system with these parameters values can be seen in Figure 4.6.
Again we have reported only one example for any possible behavior and
we can repeat considerations reported in section 4.2.1, that is note that
when delay is small the equilibrium point E is LAS, then, increasing delay,
there is a bifurcation value where Hopf bifurcation occurs and a limit cycle
arises, and finally there is another critical value above which the system
converge to the macroscopic LAS equilibrium ES .
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Figure 4.6: Solutions of delayed system with parameters taken as in section
4.2.3 and initial conditions close to equilibrium point E. x(t) (cancer cells)
on the letf and y(t) (immune cells) on the right. Values of delay are: (a)
τ = 0.1; (b) τ = 0.3; (c) τ = 0.8.
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4.2.4 EQ is unstable and there are limit cycles: H + R > 0
but HR−NS −NQ > 0
Finally let us take account of system presented in the example 2 of previous
chapter:
x′ = x(1.636 (1− 0.00476x)− y
1 + 0.02x+ 0.25y
)
y′ =
1.131x
20.19 + x
y − (0.00311x+ 0.3743)y + 0.1181
(4.49)
As we have seen, this system has the unstable equilibrium DFE and a
diseased unstable equilibrium point Ec = (9.6446, 3.0535). Moreover, in this
system limit cycles are present for τ = 0.
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Figure 4.7: Limit cycle in system without delay described in the section 4.2.4
with initial conditions close to equilibrium point Ec = (9.6446, 3.0535). On
the left phase-portait in (x,y)-plane; on the right period of solutions x(t).
Adding the delay we see in Figure 4.9 that variables x and y assume
higher values as τ increases (especially x).
Moreover, in Figure 4.8 we see also that as τ increases the period of the
cycle P increases , from a value P ' 20 (that is 198 days) for τ = 0.1, to
P ' 25 (roughly 247 days) for τ = 0.8; whereas in the system without delay
the period is P = 18 (figure 4.7).
These periods of roughly 6-8 months are rather meaningful as oscillation
times of a tumor.
To see how amplitudes of cycle, but also periods increase as delay in-
creases we have reported in Table 4.2.4 some values of period and amplitude
for different, increasing, values of τ .
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Figure 4.8: Solutions x(t) (cancer cells) of system with delay described in
the section 4.2.4 with initial conditions close to equilibrium point Ec and
delays: (a) τ = 0.1; (b) τ = 0.3; (c) τ = 0.5; (d) τ = 0.8. On the right we
reported long-term paths of x(t) and we may observe how period changes.
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Delay (τ) cycle Period Amplitude
0.1 19.5 104.9
0.2 20.8 121.6
0.3 21.9 135.1
0.4 23 145.8
0.5 24.3 154.5
0.6 25.5 161.5
0.7 26.6 167.2
0.8 27.6 171.9
0.9 28.8 175.7
1 29.8 178.9
Table 4.2: We reported in this table periods and amplitudes of cycles of
variable x(t) dependent on delay. Data are referred to system (4.49) for
which limit cycles arise also in the nondelayed case. We note how both
periods and amplitudes increase as τ increases.
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Figure 4.9: Limit-cycles in (x(t),y(t))-plane. Solutions of delay-system de-
scribed in section 4.2.4, with initial conditions close to point Ec and delays:
τ = 0.1, τ = 0.3, τ = 0.5, τ = 0.8.
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Chapter 5
Distributed delay
Generally in biological phenomena, and particularly in our case, it is rather
unrealistic to suppose that the time lag is a fixed one, whereas it is more
meaningful to think that a delay term is due to cumulative effects of many
different factors and so that is describable with a distributed delay.
As far as we know, distributed delay has not yet been considered too
much in tumor-immune system models found in literature, although it is
certainly reasonable to think that a delay term of this type can better ap-
proximate the response time of the immune system.
So, in this chapter, we examine models with distributed delay, that is
systems of the form:
x′ = x(f(x)− Φ(x, y)) (5.1)
(5.2)
y′ = β(z)y − µ(x)y + σq(x) + θ(t)
(5.3)
z =
∫ t
−∞
x(τ)K(t− τ)dτ,
Where the integration kernel K is erlangian, with probability density:
Erln,a(t) =
an
(n− 1)! t
n−1e−at t, a ∈ R+, n ∈ N+ (5.4)
for which the mean delay is T = na and the standard deviation is σ =
√
n
a .
In particular in the first section we will consider an exponential delay
(Erl1,a) whereas in the second section we will study the case Erl2,a.
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5.1 Exponentially distributed delay
Taking account of Erl1,a, we can rewrite (5.1) as a system of 3 ODEs de-
pending on the parameter a > 0:
x′ = x(f(x)− Φ(x, y))
y′ = β(z)y − µ(x)y + σq(x) (5.5)
z′ = a (x− z) .
An equilibrium point EQ = (xe, ye, ze) of this system has the same
coordinates (xe, ye) of an equilibrium point of the system without delay and
ze = xe.
We remember that in this case the value of the mean delay is T = a−1.
In the equilibrium point disease free DFE = (0, yDFE , 0), there are not
qualitatively changes due to delay, in particular:
Lemma 5.1.1. The equilibrium point disease free DFE = (0, yDFE , 0) of
system (5.1) is stable if Φ(0, yDFE)− f(0) > 0 and unstable otherwise.
Proof. The matrix associated with linearized system in the equilibriumDFE
is: 
f(0)− Φ(0, yDFE) 0 0
−µ′(0)y + σq′(0) −µ(0) β′(0)y
a 0 −a
 (5.6)
with characteristic equation:
(f(0)− Φ(0, yDFE)− λ)(−µ(0)− λ)(−a− λ) = 0. (5.7)
Since µ(0) > 0 and a > 0, the eigenvalues:
λ1 = f(0)− Φ(0, yDFE), λ2 = −µ(0), λ3 = −a,
are all negative if and only if Φ(0, yDFE)− f(0) > 0.
Let us consider therefore an equilibrium diseased point: EQ = (xe, ye, ze).
It will be useful to define H, N, S, Q, R with (4.5)-(4.9) as in the section 4,
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that is:
H = xe (f ′(xe)− ∂xΦ(xe, ye)) ,
N = −xe∂yΦ(xe, ye) < 0,
Q = yeβ′(xe) ≥ 0,
S = −yeµ′(xe) + σq′(xe),
R = β(xe)− µ(xe) = −ψ(xe) < 0.
And, thanks to these notations we can write the linearized system at EQ:
X ′ = HX +NY
Y ′ = QZ + SX +RY
Z ′ = aX − aZ.
(5.8)
The characteristic equation of the system is:
λ3 + c2λ2 + c1λ+ c0 = 0, (5.9)
where:
c2 = a− (H +R),
c1 = (−aH − aR+HR−NS),
c0 = a(HR−NS −NQ).
In the following analysis we will use a as bifurcation parameter because
equilibrium points do not depend on a and especially because a is the inverse
of mean delay value and therefore it is a biological meaningful parameter.
Moreover, in this way we can compare results with those obtained in previous
chapter for fixed lag delays.
To studying stability of the equilibrium point EQ we will use Routh-
Hurwitz rule, that is we will study the sign of the three quantities:
c2, c0, c1c2 − c0.
We know that if these quantities are positive the equilibrium point is LAS;
whereas if one of them becomes negative varying a we have the loss of
stability of the point.
Moreover, to see if Hopf bifurcations can occur, we suppose that there is a
couple of conjugate complex roots λH = ±ωH , with ωH ∈ R. By substituing
in characteristic equation and collecting real and imaginary part, we have:
ω2H =
c0
c2
=
aH(HR−NS −NQ)
aH − (H +R)
c1 − c0
c2
= 0
(5.10)
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From these simple observations we can say that there will be a loss
of stability via Hopf bifurcation when (c1c2 − c0) passes from positive to
negative, moreover, since in Hopf points we have ω2H =
c0
c2
we have to assume
c0c2 > 0.
We can also state the following:
Lemma 5.1.2. If H+R < 0 then a necessary condition to have Hopf points
varying a is that EQ is LAS in the system without delay.
Proof. This result follows immediatly from condition (5.10). In fact to have
Hopf points ω2H must be positive, and, since a > 0 and we are supposing
H +R < 0 it follows that HR−NS −NQ > 0. But we remember that the
two conditions H+R < 0, HR−NS−NQ > 0 imply that the point is LAS
for the system without delay.
Before studying in details stability of system by analyzing all possible
cases, we want to introduce an useful notation: we define p(a) = (c1c2− c0).
We have p(a) = B2a2 +B1a+B0, where
B2 = −H −R,
B1 = (H +R)2 +NQ, (5.11)
B0 = (−H −R)(HR−NS).
We can now enunciate the following:
Proposition 5.1.3. Let EQ be an equilibrium point of the system (5.5)
which is stable in the non-delayed system. That is in EQ the following
conditions hold:
H +R < 0, HR−NS −NQ > 0.
(i) If HR−NS ≤ 0 then there is ah > 0 such that if a > ah the equilibrium
point is LAS, else if 0 < a < ah then the point is unstable.
In a = ah a Hopf bifurcation occurs.
(ii) If HR−NS > 0 we have that if
(H +R)2 +NQ < −2(H +R)
√
(HR−NS), (5.12)
Then there are two values 0 < a1 < a2 of the parameter a such that
EQ is LAS for a /∈ [a1, a2] and unstable for a ∈ (a1, a2).
In a1, a2 Hopf bifurcations occur.
If, instead, (5.12) does not hold, then EQ is LAS for any a > 0.
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Proof. Firstly we remember conditions for the stability of the point:
c2 = a− (H +R) > 0 (5.13)
c0 = a(HR−NS −NQ) > 0 (5.14)
c1c2 − c0 = p(a) > 0. (5.15)
The two first conditions are satisfied thanks to hypothesys of proposition,
so we have to study the sign of p(a) varying the parameter a. Since p(a) =
B2a
2 +B1a+B0 is a second order polynomial in a, we calculate the deter-
minant:
∆ = [(H +R)2 +NQ]2 − 4(H +R)2(HR−NS). (5.16)
Let us analyze now the two cases described in the proposition.
(i) In this case we have ∆ > 0, B2 > 0 and B0 < 0; p(a) has a posi-
tive root ah and a negative one, but we are interested only in positive values
of the parameter a. Moreover, we can say that p(a) > 0, that is the point is
stable if a > ah, else if 0 < a < ah p(a) < 0 the point is unstable.
(ii) In this case we have that B2 > 0 e B0 > 0; therefore if B1 ≥ 0 the
point EQ will be LAS indipendently on the value of a, else if B1 < 0 there
will be stability switches if p(a) has positive roots, that is if the determinant
is positive.
Let us write
∆ = (B1 + 2
√
B0B2)(B1 − 2
√
B0B2),
since we are assuming B1 < 0, we have ∆ > 0 if and only if B1 < −2
√
B0B2,
that is if condition (5.12) holds. In this case roots a1 and a2 are both positive,
a2 > a1 > 0 and p(a) is positive outside the interval (a1, a2) and negative
inside; That is the point is stable if a /∈ (a1, a2) and unstable otherwise.
Finally we verify the nonzero-speed condition noting that:
dp(a)
da
|a=a1< 0 (5.17)
e
dp(a)
da
|a=a2> 0. (5.18)
Finally we analyze the last case, that is the one in which the equilibrium
point is unstable in the nondelayed system (when a = +∞).
If HR − NS − NQ < 0 the point is unstable for every a > 0, then we
consider only the case in which HR − NS − NQ > 0 that is the case in
which c0 > 0.
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Proposition 5.1.4. Let EQ be an equilibrium point of the system (5.5) in
which H +R > 0 and HR−NS −NQ > 0.
(i) If HR − NS ≤ 0 then there is an ah > 0 such that p(a) is negative if
a > ah and positive if 0 < a < ah. If ah < H + R then the point
is unstable for every a > 0. If ah > H + R then in a = ah a Hopf
bifurcation occurs, EQ is LAS in H + R < a < ah and unstable if
a > ah or a < H +R.
(ii) If HR−NS > 0 we have that if:
(H +R)2 +NQ > −2(H +R)
√
(HR−NS), (5.19)
then there are 0 < a1 < a2 such that p(a) is positive in (a1, a2) and
negative otherwise. If a2 < H +R then the point is unstable for every
a > 0. If a2 > H + R > a1 then in a = a2 a Hopf bifurcation occurs,
EQ is stable in H +R < a < a2 and unstable if a > a2 or a < H +R.
Finally, if a1 > H +R then in a = a2 and in a = a1 Hopf bifurcation
occurs, and EQ is stable if a ∈ (a1, a2) and unstable otherwise.
If, instead, (5.19) does not hold, then EQ is unstable for any a > 0.
Proof. To study the sign of p(a) we can proceed exactly as done in the pre-
vious proof, but now we have to check also the sign of c2 = a− (H +R). In
both cases (i) and (ii) it is B2 < 0.
(i) In this case B0 > 0 and ∆ > 0 so p(a) has a positive root ah and a
negative one. For a > ah it is p(a) < 0 and for 0 < a < ah it is p(a) > 0.
Now we have to verify the sign of c2 = a− (H +R).
If ah < H+R then c2 < 0 when p(a) > 0 and the point is unstable for every
a > 0.
If ah > H +R then for H +R < a < ah we have c2 > 0 and p(a) > 0, then
the point is stable if a ∈ (H +R, ah) and unstable otherwise.
In a = ah conditions (5.10) hold, and proceeding as in the previous proof we
can prove that the nonzero-speed condition holds too; then ah is an Hopf
point. In a = H + R conditions (5.10) do not hold and then a = H + R is
not a Hopf point.
(ii) In this case B0 < 0; therefore if B1 < 0 there are not positive real
roots, whereas if B1 > 0 there are two positive roots a1 < a2 if ∆ =
(B1 + 2
√
B0B2)(B1 − 2
√
B0B2) > 0, that is if B1 > 2
√
B0B2.
Then if (5.19) does not hold p(a) < 0 for every a > 0 and EQ remains
unstable.
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We assume now that (5.19) holds. In this case p(a) is positive if a stays
in (a1, a2) and negative otherwise.
However if a2 < H+R, in (a1, a2) we have c2 < 0 then EQ remains unstable
for every a > 0. If a2 > H +R then for H +R < a < a2 we have c2 > 0 and
p(a) > 0, then the point is stable if a ∈ (H +R, a2) and unstable otherwise.
In a = a2 a Hopf bifurcation occurs. Finally if a1 > H + R then c2 > 0 in
(a1, a2) and the point is stable for a ∈ (a1, a2) and unstable otherwise. As
above we can easily verify that in a = a2, a = a1 Hopf bifurcations occur.
5.1.1 Numerical results
To see an example of what we proved above, we perform numerical simula-
tions considering the system (5.5) where parameters are the same as these
in section 4.2.3.
Equilibrium points of non-delayed system are the same points reported
in section 4.2.3; remembering that in this case we have a 3-dimensional
system and, at equilibria ze = xe.
In Em = (8.3724, 1.6086, 8.3724) it is HR − NS > 0 and the condition
(5.12) also holds; therefore two bifurcations occur when a passes through:
a1 = 0.0155,
a2 = 3.8067.
These values correspond to mean delays:
τ1 = 1a1 = 64.51,
τ2 = 1a2 = 0.2627 which is comparable to bifurcation values obtained taking
into account discrete delays (in the same system with discrete delay
bifurcation value is τbif = 0.2564).
Since treal = 9.9 tadim days, we note that τ2 corresponds to 2.6 days, a
value quite realistic for a delay of this type; whereas τ1 corresponds roughly
to 37 days which, instead, is a value difficult to achieve for a delay in prolif-
eration rate of immune cells.
In Proposition 5.1.3 we have seen that the system is stable for a > a2.
In a = a2 a Hopf bifurcation occurs and system becomes unstable. Then,
continuing decreasing the parameter there is another bifurcation when a
passes through a = a1 and stability is recovered.
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In Figure 5.1 we note as the equilibrium point is LAS if the parameter
a lies outside the interval (a1, a2).
Moreover, thanks to numerical simulations we see that when a stays in
the interval (a1, a2), where system is unstable, there are two different possi-
ble behaviors. If a is less than a2, but greater than a critical value ac then
system exhibits a limit cycle whose oscillations have amplitude increasing as
a decreases (figure 5.3). In a = ac amplitude of cycle is such that the cycle
is tangent to the seperatrix curve passing through the unstable equilibrium
point U ; therefore, diminishing again the value of a the system go into the
attraction basin of the macroscopic equilibrium point EM . In fact, from
Figure 5.2 we can notice that system converges to EM when a < ac.
Decreasing further a the behavior changes again in a1, in fact, as stated
in Proposition 5.1.3 the point Em is stable for a < a1.
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Figure 5.1: Solutions x(t) (cancer cells) of the system with parameters as in
section 5.1.1, initial conditions close to equilibrium point Em and parameter
values outside the range of instability: a = 5 > a2 in the left and a = 0.005 <
a1 in the right.
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Figure 5.2: Solutions x(t) (cancer cells) of the system with parameters as in
section 5.1.1, initial conditions close to equilibrium point Em and in which
the parameter a = 1 lies in the instability interval and it is less than ac.
In Figure 5.3 are reported graphs of solutions x(t) of tumor variable
when the parameter a lies in the range where cyclic dynamics arise. In the
right half of this figure, solutions are drawing in the final interval of time
of lenght 100 units. Thanks to this magnification it is possible to see an
increasing trend in periods of amplitudes of long-term time cyclic paths.
As we did in section 4.2.1 for a system with discrete delay, we show in Figure
5.4 a phase portrait that summarizes different long-term paths of solutions
x(t) of system (5.5). We can observe how the point Em is LAS for values of
parameter a greater than a1, and exhibits limit cycles of increasing ampli-
tude as delay increases (that is as a decreases). Finally, when a < ac, limit
cycles break down and we have convergence to the macroscopic equilibrium
EM .
Also in this case, as in the case of discrete delay we can observe how not
only amplitudes of cycle, but also periods increase as delay increases. To
see this we have reported in Table 5.1.1 values of period and amplitude of
limit cycles for different, increasing, values of τ .
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Figure 5.3: Solutions x(t) (cancer cells) of the system with parameters as in
section 5.1.1, initial conditions close to equilibrium point Em and values of
parameter: (a) a = 3.2; (b) a = 2; (c) a = 1.5. In the right half of figure
are reported graphs where in abscissa is selected only a final interval of time
of 100-units lenght.
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Figure 5.4: Phase portrait in (x,y)-plane of solutions of system with param-
eters as in section 5.1.1 for different values of parameter a.
Value of a Mean delay (a−1) Cycle Period Amplitude
3.6 0.278 11.4 34.2
3.4 0.294 12 44.9
3.2 0.313 12.5 55.6
3 0.333 13.1 67.6
2.8 0.357 13.8 81.4
2.6 0.385 14.6 97
2.4 0.417 15.5 116.1
2.2 0.455 16.7 139.2
2 0.5 18.3 165.1
1.8 0.555 20.5 198.4
Table 5.1: We reported in this table periods and amplitudes of cycles of vari-
able x(t) dependent on delay. Data are referred to system with parameters
as in section 5.1.1, in the range of delay values when limit cycle is present.
We note how both periods and amplitudes increase as delay increases (that
is as the parameter a decreases).
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5.2 Strong Erlangian delay
We consider now a distrubuted delay with distribution Erl2,a. System (5.1)
can be rewritten in this case as a system of 4 ODEs:
x′ = x(f(x)− Φ(x, y)) (5.20)
y′ = β(z)y − µ(x)y + σq(x) + θ(t)
u′ = a (x− u)
z′ = a (u− z)
where a ∈ R+
An equilibrium point EQ = (xe, ye, ue, ze) has as coordinates the coor-
dinates (xe, ye) of the correspondent equilibrium in non delayed-system and
ue = ze = xe. The mean delay is given by T = 2a . So we will take a as
bifurcation parameter in this section too.
In this case again, proceeding as in the previous section, we easily prove
that delay does not affect stability of disease free equilibrium DFE =
(0, yDFE , 0, 0).
Then we will consider only equilibria with non null disease
EQ = (xe, ye, ue, ze), and we define:
H = xe
(
f ′(xe)− ∂xΦ(xe, ye)
)
(5.21)
N = −xe∂yΦ(xe, ye) < 0 (5.22)
Q = yeβ′(xe) ≥ 0 (5.23)
S = −yeµ′(xe) + σq′(xe) (5.24)
R = β(xe)− µ(xe) = −ψ(xe) < 0. (5.25)
The linearized system is:
X ′ = HX +NY (5.26)
y′ = QZ + SX +RY (5.27)
U ′ = aX − aU (5.28)
Z ′ = aU − aZ (5.29)
and the characteristic equation:
λ4 + b3λ3 + b2λ2 + b1λ+ b0 = 0, (5.30)
where:
b3 = 2a−H −R,
b2 = a2 − 2aH − 2aR+HR−NS,
b1 = a2(−H −R) + 2a(HR−NS),
b0 = a2(HR−NS −NQ).
(5.31)
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these coefficients are positive if two following conditions hold:
H +R < 0, (5.32)
HR−NS > 0.
To studying stability of system we apply Routh-Hurwitz rule. So we
have to study the sign of:
b0, b1, b3,
g(a) = (b1b2 − b3b0)b3 − b21;
(5.33)
And we have that if these four terms are positive, so the corresponding point
is LAS, else if one of them is negative, the point is unstable.
If, as an example, we consider a LAS point in non delayed-system, that
is a point where
H +R < 0, HR−NS −NQ > 0, (5.34)
we have that b0 > 0 and b3 > 0 indipendently of the value of a.
If, moreover, we take the stronger assumption: HR −NS > 0 we have
that b1 > 0 for any a. In this case we have to study how the sign of g(a)
varies, varying a. We can rewrite:
g(a) = a(B4a4 +B3a3 +B2a2 +B1a+B0), (5.35)
where:
B4 = 2(−H −R) > 0;
B3 = 4((H +R)2 +NQ);
B2 = −2(H +R)((H +R)2 + 2(HR−NS +NQ));
B1 = (H +R)2(4(HR−NS) +NQ);
B0 = −2(H +R)(HR−NS)2 > 0.
(5.36)
If g(a) > 0 for any value of a the equilibrium point is always LAS, otherwise
changes of stability will occur if a passes through simple roots of g(a).
5.2.1 Numerical results
We consider here the system with same parameters as in the previous section,
that is with parameter values introduced in section 4.2.3.
We will observe how changes the stability of the equilibrium point
Em = (8.3724, 16086, 8.3724, 8.3724).
Solving numerically the equation g(a) = 0, where g(a) is the function
described in (5.35), we find three real roots: a0 = 0, a1 = 0.0545, a2 =
7.7217; and in these roots the derivative g′(ai), i = 0, 1, 2 is non null.
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Then in a = a1 and in a = a2 Hopf bifurcations will occur, and system
passes from stability to instability in a1 and from instability to stability in
a2.
Mean delays corresponding to these bifurcation values are:
T1 =
2
a1
= 36.7
T2 =
2
a2
= 0.259
T1 corresponds to roughly one year, and so is surely a value too high to be bi-
ologically meaningful, whereas T2 corresponds roughly 2.5 days, and is com-
pletely compatible with critical values found in previous sections (for exam-
ple, the same system with discrete delay has as bifurcation value τ = 0.2564,
whereas with exponentially distributed delay the mean delay corresponding
to critical value in which a Hopf bifurcaion occurs and system passes from
stability to instability is τ2 = 0.2627).
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Figure 5.5: Solutions x(t) (cancer cells) of the system with strong erlangian
delay described in section 5.2.1 with initial conditions close to equilibrium
point Em and a = 10.
In Figure 5.5, 5.6 and 5.7 we observe a behavior analogous to that re-
ported in previous section for exponentially distributed delay.
For values of a greater than a1 the equilibrium point remains LAS (figure
5.5). Between a1 and a2 the equilibrium point is unstable and we have a
cyclic dynamics until a is greater than a value ac (figure 5.6).
When a < ac the cycle breaks down and system converges to macroscopic
equilibrium EM = (447.134, 0.173, 447.134, 447.134) that is LAS for any
value of the parameter a.
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Figure 5.6: Solutions x(t) (cancer cells) of the system of section 5.2.1 with
initial conditions close to equilibrium point Em. Values of parameter are:
(a) a = 7, (b) a = 5, (c) a = 3.
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Figure 5.7: Solutions x(t) (cancer cells) of the system of section 5.2.1 with
initial conditions close to equilibrium point Em. On the left a = 1, on the
right a = 0.1.
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Chapter 6
Interactions between delay
and therapy
In this chapter we will take account of models with delay and immunother-
apy terms. We perform a numerical analysis taking some significant exam-
ples and we make some observations remarking both biological and mathe-
matical interesting features.
We consider again, as we did in section 3.5, a boli-based therapy of the
form:
θ(t) = 0.1181 exp (−ψMod(t, T )) , (6.1)
and then we consider different systems with delay either discrete or dis-
tributed.
Again simulations will be made by varying T and ψ to analyze any
differences in therapy effects when different times of administration and
different clearance time of the drug are considered.
We remember that T represents the administartion time of the therapy; ψ
is a measure of the clearance time (it is proportional to the inverse of the
half life of the drug in the organism); and the mean value of the therapy is:
M = θA
e−Tψ
(−1 + eTψ)
Tψ
. (6.2)
and we have taken θA = 0.1181.
For further explications on parameter of boli-based therapy see section 3.5.2.
The values of T will be taken either within a biologically reasonable
range (T ∈ [0.1, 3], that is from 1 day to 1 month), or, if the system exhibit
oscillatory dynamics, in the order of periods of limit cycles.
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6.1 Discrete delay; no limit cycle model
As a first example we take the model presented in section 4.2:
x′ = x(1.636 (1− 0.002x)− y)
y′ =
1.131xτ
20.19 + xτ
y − (0.00311x+ 0.3743)y + 0.1181 + θ(t).
(6.3)
And we remember that this system without therapy term has a LAS
equilibrium point Emicro = (8.1897, 1.6092); around which limit cycles arise
via Hopf bifurcations if the delay exceeds the value τbif = 0.2692.
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Figure 6.1: Solutions x(t) of system (6.3) with delay τ = 0.1. (a) system
without therapy. (b) ψ = 0.025, T = 0.1. (c) ψ = 0.1, T = 1. (d) ψ = 0.9,
T = 3. Mean values of therapy are: (b) M=0.1180. (c) M=0.1124. (d)
M=0.0408.
In Figure 6.1 we can see the behavior of the system (6.3) with delay
τ = 0.1 and initial conditions close to the point Emicro . We have reported
the case without treatment (the equilibrium point is LAS), and cases with
different therapies (various values of ψ and T ).
We see that in each case the values taken by variable x(t) of cancer cells
decrease compared to the case without therapy; but with ψ = 0.9 and T = 3
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(therapy less strong among those considered), an oscillation is produced.
We also notice that tumor eradication is never reached.
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Figure 6.2: Solutions x(t) of system with delay τ = 0.6. (a) system without
therapy. (b) ψ = 0.025, T = 0.1. (c) ψ = 0.1, T = 1. (d) ψ = 0.9,
T = 3. Mean values of therapy are: (b) M=0.1180. (c) M=0.1124. (d)
M=0.0408.
In Figure 6.2 we observe behavior of solutions of the system with τ = 0.6.
In this case without therapy term the model exhibits oscillatory dynam-
ics as reported in the first graph of Figure (6.2-(a)).
We can notice as adding therapies with different, but realistic, param-
eters (ψ = 0.025 e T = 0.1, ψ = 0.1 e T = 1, ψ = 0.9, T = 3) we still
have limit cycles , but the size of oscillations decreases as the clearance time
increases (so as ψ decreases) and as T decreases (figure 6.3 ).
For the system with delay τ = 0.6 we performed numerical simulations
also choosing T = 17 (close to the period of oscillations of the system without
therapy).
As an example in the Figure 6.4 we can see how, taking ψ = 0.025, res-
onance effects arise.
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Figure 6.3: Zoom of Figure 6.2. Periods of solutions x(t) of system with
delay τ = 0.6. On the left ψ = 0.025, T = 0.1. On the right ψ = 0.1, T = 1.
Down ψ = 0.9, T = 3.
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Figure 6.4: Solutions x(t) (on the left) and zooming (on the right) when
τ = 0.6, ψ = 0.025, T = 17.
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Figure 6.5: Solutions x(t) of the system with delay τ = 1.2. On the left
system without therapy. On the right ψ = 0.025, T = 0.1. Down ψ = 0.9,
T = 3.
Finally, we considered system (6.3) with delay τ = 1.2. For this value,
without therapy, starting simulations with initial conditions close to Emicro,
solutions converge to the other LAS equilibrium point: Emacro (first graph
in the figure 6.5).
In this case we add therapy with different parameter values choosed
in biological meaninguful ranges. We observe that adding these different
therapies, solutions do not converge to Emacro, but, instead, the system
show oscillatory dynamics with cycles of amplitude more or less high (figure
6.5 and 6.6).
In Figures 6.5 and 6.6 are reported only two cases with extreme param-
eters of therapies (in realistic intervals): ψ = 0.025 - T = 0.1 and ψ = 0.9 -
T = 3
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Figure 6.6: Zoom of the Figure 6.5.Periods of solutions of system with delay
τ = 1.2. On the left ψ = 0.025, T = 0.1. On the right ψ = 0.9, T = 3.
6.2 Discrete delay; limit cycle model
In this section we observe the behavior of the model presented in section
3.5, adding a therapy term.
The system we consider is then:
x′ = x(1.636 (1− 0.00476x)− y
1 + 0.02x+ 0.25y
)
y′ =
1.131xτ
20.19 + xτ
y − (0.00311x+ 0.3743)y + 0.1181 + θ(t)
(6.4)
We consider for example the case τ = 0.3, in which system without
therapy exhibit oscillations of period P ' 22 (see section 4.2.4).
In Figure 6.7 we note as, taking realistic parameters for therapy, dynam-
ics qualitatively remains the same; with oscillations of lower period as slower
is the clearance time of therapy.
Choosing instead times of administration close to the period P we have
again resonance effects and chaos, as already seen in the previous section
and in the case without delay (figure 6.8, 6.9, 6.10).
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Figure 6.7: Solutions x(t) of system (6.4) with delay τ = 0.3 (a) ψ = 0.025,
T = 0.1. (b) ψ = 0.025, T = 3. (c) ψ = 0.1, T = 1. (d) ψ = 0.9, T = 3.
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Figure 6.8: Solutions x(t) of system (6.4) with delay τ = 0.3 ψ = 0.025. On
the left T = 22; on the right T = 25.
101
6.2CHAPTER 6. INTERACTIONS BETWEEN DELAY AND THERAPY
0 100 200 300 400 500 600
0
20
40
60
80
100
120
140
Time : t
Ca
nc
er
 c
el
ls 
: x
 (t)
0 100 200 300 400 500 600
0
20
40
60
80
100
120
140
Time : t
Ca
nc
er
 c
el
ls 
: x
 (t)
Figure 6.9: Solutions x(t) of the system (6.4) with delay τ = 0.3, ψ = 0.9.
On the left T = 20; on the right T = 25.
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Figure 6.10: Phase portrait in the plane (x,y). System (6.4)with delay τ =
0.3. On the left ψ = 0.025 and T = 25; on the right ψ = 0.9 and T = 20;
down ψ = 0.9 and T = 25.
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6.3 Exponentially distributed delay
We conclude simulations of models with therapy taking as last example the
system with exponentially distributed delay studied in section 5.1.1.
We remember that with these parameters Hopf bifurcations occur at the
equilibrium Em when a passes through:
a1 = 0.0155,
a2 = 3.8067.
In simulations reported below initial conditions are taken close to Em, to
study possible changes of stability due to therapy term, or even resonance
effects.
As a first example we take simulations with a = 5. For this value of param-
eter without therapy the equilibrium point is still LAS (figure 6.11-(a)).
In Figure 6.11 are collected some examples illustrating different thera-
pies.
Adding a therapy term and varying its parameters taking values in bio-
logical meaningful intervals as in previous sections, we see again that equi-
librium point moves (the xe value decreases). We have nevertheless stability
((b) and (c)), or small oscillations around new equilibrium point; whose
maximal amplitude is less than the value of steady state in system without
therapy (figure 6.11-(d)).
We see now the case a = 2. Without therapy the system has oscillatory
dynamics with cycles of period P ' 18 (see section 5.1). In this case we
consider first therapy with different ψ and realistic administration times
(T ∈ [0.1, 3]), and then T close to the period P .
In the Figure 6.12 we see as dynamics remains oscillatory, for ψ = 0.025
and T = 0.1 amplitude of oscillations increases very slowly, whereas when
ψ = 0.9 and T = 3 we have immediately convergence to a limit cycle whose
amplitude is less than that of system without therapy.
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Figure 6.11: Solutions x(t) of the system with exponential delay with pa-
rameter as in section 5.1.1, therapy term and a = 5. (a) system without
therapy. (b) ψ = 0.025, T = 0.1. (c) ψ = 0.1, T = 1. (d) ψ = 0.9, T = 3.
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Figure 6.12: Solutions x(t) of system with exponential delay with parameter
as in section 5.1.1, therapy term and a = 2. On the left ψ = 0.025, T = 0.1.
On the right ψ = 0.9, T = 3. Down system without therapy.
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In Figures 6.13 and 6.14 we observe that also in this case, taking admin-
istration times close to period of limit cycle of the system without therapy,
there can occur modulation effects or resonances.
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Figure 6.13: Solutions x(t) of the system with exponential delay with param-
eter as in section 5.1.1, therapy term and a = 2 and T = 18. On the right
ψ = 0.025; in the centre ψ = 0.1; on the right ψ = 0.9.
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Moreover, regarding figure 6.14, we can hypothesize that system is chaotic.
We have then calculated the Lyapunov spectrum of this system with the soft-
ware NDT (Nonlinear Dynamics Toolbox) developed by J.Reiss. We have
obtained that the dominant exponent is strictly positive indicating that
probably dynamics is really chaotic.
However, we remark that the administration time taken to obtain system
of figure 6.14, is very unrealistic (T = 18, that is roughly 6 months); then
this result have only a mathematical interest.
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Figure 6.14: Phase portrait in (x,y)-plane. Solutions of system with expo-
nential delay with parameter as in section 5.1.1, therapy term and a = 2.
ψ = 0.1 and T = 18.
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Finally in Figure 6.15 we have taken a = 1. We note as in system without
therapy solutions converge to macroscopic equilibrium EM , whereas adding
different therapies system exhibit a limit cycle (and therefore the size of
tumor, even if oscillating, remains smaller than in case without therapy).
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Figure 6.15: Solutions x(t) of the system with exponential delay with param-
eter as in section 5.1.1, therapy term and a = 1. On the left without therapy;
in the centre ψ = 0.025 and T = 0.1; on the right ψ = 0.9 and T = 3.
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